unit
medic
director
ask
hospit
administr
recommend
lead
process
limit
practic
variabl
better
align
hospit
resuscit
practic
evidencebas
guidelin
code
great
deal
variabl
depend
upon
time
day
staff
present
locationwhich
follow
would
suggest
increas
frequenc
advanc
cardiovascular
life
support
acl
train
becom
annual
requir
clinic
practitionersb
interview
hospit
staff
use
delphi
method
process
enumer
optim
resuscit
practicesc
implement
american
heart
associ
aha
get
guidelin
resuscit
programd
develop
resuscitationspecif
privileg
requir
hospit
credenti
answer
coften
first
step
perform
improv
project
research
current
valid
program
accord
american
heart
associ
aha
get
guidelin
program
develop
identifi
improv
opportun
allow
perform
comparison
among
hospit
reduc
medic
error
datadriven
peer
review
program
includ
specif
uptod
consensu
statement
guidelin
resuscit
atrial
fibril
heart
failur
stroke
referenceamerican
heart
associ
http
wwwheartorgheartorghealthcareresearchgetwiththeguidelineshfstrokegetwiththeguidelinesstrokehomepagegetwithguidelinesstrokeoverview
male
type
diabet
mellitu
hypertens
hyperlipidemia
present
fever
hypotens
decreas
urin
output
admit
intens
care
unit
sepsi
due
pyelonephr
addit
broadspectrum
antibiot
patient
receiv
one
liter
fluid
resuscit
salin
two
hour
present
blood
pressur
current
mmhg
temperatur
puls
rate
beatsminut
respiratori
rate
breathsminut
hematocrit
blood
sugar
mgdl
serum
lactat
mgdlwhich
follow
like
improv
mortal
particular
patient
continu
fluid
resuscit
colloid
addedb
intens
insulin
therapi
maintain
euglycemiac
vasopressor
therapyd
bicarbon
infusion
transfus
prbc
answer
cthi
patient
respond
aggress
fluid
resuscit
per
sepsi
guidelin
point
within
h
attempt
fluid
resuscit
vasopressor
therapi
indic
shown
improv
mortal
intens
insulin
therapi
fluid
resuscit
colloid
recommend
critic
ill
past
howev
recent
trial
fail
show
definit
benefit
therapi
sever
sepsi
intens
insulin
therapi
increas
risk
hypoglycemia
shown
improv
mortal
acut
set
sepsi
referencedelling
rp
levi
mm
carlet
jm
et
al
surviv
sepsi
campaign
intern
guidelin
manag
sever
sepsi
septic
shock
crit
care
med
clinic
outcom
reduc
use
chlorhexidin
bath
compar
soap
water
bath
icu
patient
global
infect
ratesb
ventilatorassoci
pneumonia
vap
ratesc
catheterassoci
urinari
tract
infect
cauti
ratesd
answer
dall
answer
correct
bath
chlorhexidineimpregn
wipe
associ
global
specif
infect
rate
reduct
studi
icu
patient
compar
soap
water
bath
referencemichael
w
climo
et
al
effect
daili
chlorhexidin
bath
hospitalacquir
infect
n
engl
j
med
true
concern
postop
cognit
dysfunct
pocd
pocd
less
like
occur
oper
region
anesthesia
gener
anesthesiab
like
major
minor
operationsc
like
cardiac
surgeri
type
surgeryd
like
age
younger
patients
answer
eth
risk
pocd
increas
age
type
durat
surgeri
low
incid
among
age
group
associ
minor
surgeri
pocd
common
adult
patient
age
hospit
discharg
major
noncardiac
surgeri
elderli
age
year
older
signific
risk
longterm
cognit
problem
may
last
long
month
becom
perman
referencerasmussen
ls
postop
cognit
dysfunct
incid
prevent
best
practic
research
clin
anaesthesiol
femal
aid
admit
failur
thrive
experienc
chronic
diarrhea
anorexia
famili
struggl
get
eat
bite
per
day
obviou
opportunist
infect
famili
distress
caus
continu
declin
appear
lack
oral
intak
request
home
iv
nutrit
establishedon
physic
exam
temperatur
heart
rate
bpm
blood
pressur
mmhg
respiratori
rate
breathsmin
height
weight
kg
appear
chronic
ill
bitempor
wast
hair
thinningwhich
follow
statement
regard
home
total
parenter
nutrit
tpn
true
surviv
qualiti
life
improv
patient
metastat
cancer
receiv
home
tpnb
surviv
qualiti
life
improv
patient
aid
receiv
home
tpnc
surviv
qualiti
life
improv
patient
short
bowel
crohn
diseas
receiv
home
tpnd
evid
support
use
home
tpn
answer
cmean
surviv
aid
patient
metastat
cancer
receiv
home
tpn
failur
thrive
month
evid
home
tpn
prolong
life
improv
qualiti
life
patient
home
tpn
expens
indic
select
circumst
patient
short
bowel
result
treatment
crohn
diseas
pseudoobstruct
good
respons
home
tpn
patient
tpn
increas
qualityadjust
year
life
patient
costeffect
littl
evid
support
use
home
tpn
chronic
diseas
result
malnutrit
referenceshoda
jatoi
burn
j
loprinzi
c
kelli
patient
advanc
incur
cancer
ever
sent
home
total
parenter
nutrit
cancer
dk
keef
sj
treatment
intestin
failur
home
parenter
nutrit
nat
clin
pract
gastroenterol
hepatol
man
ischem
heart
failur
new
york
heart
associ
nyha
function
class
iv
sever
chronic
obstruct
pulmonari
diseas
admit
icu
cardiac
decompens
third
admiss
past
month
difficulti
activ
daili
live
patient
current
medic
carvedilol
lisinopril
spironolacton
furosemid
beta
agonist
inhal
previous
taken
warfarin
aspirin
signific
bleed
gastric
ulcer
week
prior
admiss
prompt
discontinuationtwo
year
ago
automat
implant
cardiovert
defibril
aicd
place
transven
approach
persist
ventricular
arrhythmia
past
week
aicd
fire
six
time
patient
daughter
report
sinc
last
hospit
discharg
patient
spent
time
sleep
reclin
bed
poor
appetiteon
physic
examin
patient
dyspneic
poorli
commun
deni
current
chest
painwhich
follow
correct
treatment
initi
milrinon
infusionb
angiographi
possi
ble
percutan
interventionc
insert
intraaort
balloon
pumpd
deactiv
aicd
aicd
recalibr
answer
dthi
patient
multipl
indic
definit
advanc
chronic
heart
failur
includ
symptombas
high
new
york
heart
associ
nyha
classif
sever
chronic
obstruct
pulmonari
diseas
left
ventricular
eject
fraction
palli
care
appropri
offer
reason
intervent
time
deactiv
automat
implant
cardiovert
defibril
aicd
failur
deactiv
aicd
leav
mani
patient
vulner
inappropri
devic
discharg
unnecessari
discomfort
intens
anxieti
measur
infus
posit
inotrop
use
temporari
basi
plan
definit
therapi
use
intermitt
infus
control
symptom
recommend
ahaacc
guidelin
unless
patient
await
definit
therapi
transplant
man
admit
larg
subarachnoid
hemorrhag
sah
ruptur
cerebr
aneurysm
spontan
movement
past
week
remain
intub
concern
patient
brain
deathwhat
test
commonli
use
diagnos
brain
death
situat
cerebr
angiographyb
apnea
testingc
demonstr
absent
cranial
nerv
reflexesd
demonstr
fix
dilat
pupils
perform
transcrani
doppler
ultrasonographi
answer
bbrain
death
defin
lack
cerebr
function
continu
cardiac
activ
state
requir
support
artifici
mean
individu
determin
brain
death
lifesustain
therapi
may
withdrawn
occur
without
consent
famili
import
ongo
commun
famili
allow
withdraw
care
without
conflict
hospit
develop
specif
protocol
line
state
law
diagnos
patient
brain
deaththre
element
demonstr
diagnosi
brain
death
patient
widespread
cortic
damag
complet
absenc
respons
extern
stimuli
second
patient
evid
medullari
function
demonstr
lack
oculovestibular
corneal
reflex
common
test
assess
pupillari
reaction
light
final
evid
medullari
activ
manifest
apnea
specif
protocol
develop
perform
apnea
test
referencesallen
la
stevenson
lw
gradi
kl
et
al
aha
scientif
statement
decis
make
advanc
heart
failur
circul
efm
diagnosi
brain
death
n
engl
j
med
woman
admit
sever
nausea
diarrhea
complain
nausea
diarrhea
began
earli
afternoon
report
ate
sandwich
street
vendor
lunch
began
experienc
symptom
sever
hour
later
report
similar
experi
past
recent
travel
histori
contact
sick
person
treat
cours
ciprofloxacin
urinari
tract
infect
month
ago
otherwis
healthyon
physic
exam
heme
neg
abdomen
mildli
tender
afebril
organ
like
caus
patient
acut
diarrheal
ill
campylobact
jejuni
b
salmonella
enteritidi
c
staphylococcu
aureu
c
difficil
e
e
coli
answer
cmost
acut
diarrhea
caus
viral
infect
adeno
norwalk
rotaviru
selflimit
caus
bacteria
common
agent
urban
area
campylobact
salmonella
shigella
escherichia
coli
protozoa
giardia
lamblia
entamoeba
histolytica
account
common
causeson
mechan
acut
diarrhea
ingest
preform
toxin
sever
speci
bacteria
aureu
c
perfringen
bacillu
cereu
produc
toxin
produc
syndrom
commonli
design
food
poison
occur
within
h
ingest
case
bacteria
need
establish
intralumin
infect
ingest
toxin
alon
produc
diseas
symptom
subsid
toxin
clear
usual
next
day
symptom
usual
local
fever
minim
referenceloir
yl
baron
f
gautier
review
staphylococcu
aureu
food
poison
genet
mol
re
femal
histori
renal
transplant
year
prior
present
headach
fever
purul
rhinorrhea
occur
past
day
steroid
intermitt
past
month
episod
acut
rejectionon
physic
exam
letharg
abl
respond
question
appropri
lung
clear
auscult
diffus
maxillari
tender
note
black
nasal
dischargewhich
follow
like
caus
ill
coccidioid
immiti
b
rhizopu
mucormycosi
c
histoplasmosi
capsulatum
blastomyc
dermatitidi
e
cryptococcu
neoforman
answer
bthi
patient
symptom
consist
mucormycosi
invas
fungal
infect
caus
varieti
fungi
commonli
rhizopu
rapid
opportunist
infect
invad
vascular
system
lifethreaten
condit
urgent
consult
otolaryngolog
infecti
diseas
warrant
mucormycosi
acquir
inhal
spore
found
ubiquit
soil
decay
fruit
old
bread
although
black
eschar
classic
find
mucormycosi
present
less
half
patient
presenc
black
eschar
indic
vascular
invas
predict
poor
prognosisth
prognosi
mucormycosi
poor
vari
mortal
rate
depend
form
sever
patient
immunocompromis
significantli
higher
mortal
rate
rhinocerebr
form
mortal
rate
dissemin
mucormycosi
poor
prognosi
mortal
rate
referenceroden
mm
zaouti
te
buchanan
wl
et
al
epidemiolog
outcom
mucormycosi
review
report
case
clin
infect
di
male
past
medic
histori
diabet
mellitu
ii
hypertens
hypothyroid
esrd
hemodialysi
day
per
week
present
right
leg
swell
leg
painimag
confirm
lower
extrem
deep
vein
thrombosi
dvt
patient
want
know
treatment
option
besid
warfarin
state
grandma
bled
much
drug
attend
physician
explain
choic
rivaroxabanb
dabigatranc
warfarin
heparin
bridg
minimum
day
answer
cthere
sever
altern
coumadin
treatment
dvt
import
know
advantag
disadvantag
patient
hemodialysi
limit
medic
option
dvt
treatment
rivaroxaban
avoid
crcl
mlmin
dabigatran
studi
hd
patient
patient
crcl
mlmin
popul
exclud
dvtpe
trial
howev
warfarin
requir
renal
adjust
safe
use
hd
patient
appropri
monitor
inr
referencesdabigatran
packag
insert
http
bidocsboehringeringelheimcombiwebaccessviewservlets
docbaserenetnt
folderpathprescrib
access
access
may
packag
insert
http
wwwxareltohcpcom
access
may
femal
present
newonset
right
hemiplegia
ct
scan
perform
found
larg
leftsid
middl
cerebr
arteri
stroke
past
medic
histori
signific
hypertens
diabet
hospit
cours
uneventfulprior
transfer
skill
nurs
facil
patient
initi
physic
therapi
make
good
progress
good
famili
support
anticip
admiss
skill
nurs
facil
live
home
medic
assist
histori
depress
psychiatr
disord
patient
famili
state
extrem
activ
lifestyl
event
concern
develop
depress
notic
seem
bit
time
request
antidepress
start
treatment
prevent
depressionwhich
follow
appropri
advic
famili
incid
depress
therefor
therapi
recommendedb
incid
depress
poststrok
therapi
recommendedc
incid
depress
lowdos
select
serotonin
reuptak
inhibitor
would
reason
choic
incid
depress
poststrok
lowdos
select
serotonin
reuptak
inhibitor
would
reason
choic
answer
bthe
incid
mild
dysthym
state
common
incid
stroke
due
loss
prior
function
possibl
due
chemic
chang
seen
cerebr
cortex
durat
condit
may
last
sever
weeksth
lifetim
preval
depress
stroke
cumul
incid
within
year
stroke
appear
metaanalysi
perform
reveal
definit
benefit
pharmacolog
therapi
prevent
depress
stroke
small
statist
signific
benefit
psychotherapi
appropri
approach
would
advis
patient
famili
follow
sign
depress
consid
treatment
diagnosi
becom
appar
patient
current
sign
depress
appropri
sign
griev
loss
function
referencemosnik
william
ls
kroenk
k
callahan
c
symptom
poststrok
depress
distinct
syndrom
compar
geriatr
depress
neurolog
suppl
femal
admit
communityacquir
pneumonia
past
medic
histori
includ
diabet
hypothyroid
vitamin
defici
clinic
cours
improv
antibiot
therapi
readi
discharg
ask
review
need
lipidlow
therapi
lipid
panel
drawn
admiss
current
take
lipidlow
therapywould
benefit
start
statin
ye
diabeticb
ye
year
oldc
ldl
unknownd
need
assess
hemoglobin
decid
initi
therapi
answer
adiabet
one
four
statin
benefit
group
accord
new
lipid
guidelin
american
colleg
cardiolog
evid
show
mgdl
reduct
ldl
statin
reduc
atherosclerot
cardiovascular
diseas
ascvd
risk
four
major
statin
benefit
group
follow
clinic
ascvd
ldl
age
year
diabet
ldl
without
clinic
ascvd
age
year
ldl
estim
ascvd
risk
without
clinic
ascvd
diabet
diabet
age
classifi
accord
patient
ascvd
risk
moder
intens
statin
highintens
statin
initi
ldl
valu
need
order
initi
statin
therapi
diabet
patient
addit
age
alon
factor
help
calcul
risk
lastli
hemoglobin
influenc
initi
statin
therapi
referenceston
nj
robinson
j
lichtenstein
ah
et
al
accaha
guidelin
treatment
blood
cholesterol
reduc
atherosclerot
cardiovascular
risk
adult
report
american
colleg
cardiologyamerican
heart
associ
task
forc
practic
guidelin
j
coll
cardiol
follow
characterist
compar
vancomycin
decreas
nephrotox
higher
dosesb
increas
intrapulmonari
penetrationc
increas
incid
thrombocytopeniad
above
none
answer
dall
answer
correct
vancomycin
current
main
stay
methicillinresist
staphylococcu
aureu
mrsa
infect
newer
agent
see
increas
use
due
better
side
effect
profil
tissu
penetr
linezolid
may
prefer
treat
nosocomi
pneumonia
due
mrsa
referencechastr
j
et
al
european
perspect
updat
manag
nosocomi
pneumonia
due
methicillinresist
staphylococcu
aureu
year
experi
linezolid
clin
microbiol
infect
suppl
dosag
benzodiazepin
cardiac
patient
admit
hospit
associ
increas
risk
sudden
deathb
increas
heart
failur
hospitalizationc
increas
risk
myocardi
infarctiond
increas
risk
dementia
none
answer
correct
answer
ath
adjust
incid
sudden
death
significantli
associ
increas
benzodiazepin
dosag
year
followup
studi
referencewu
ck
et
al
antianxieti
drug
use
cardiovascular
outcom
patient
myocardi
infarct
nation
wide
assess
atherosclerosi
yearold
femal
admit
communityacquir
pneumonia
chest
xray
note
mark
pleural
effus
plan
perform
therapeut
thoracentesi
larg
rightsid
pleural
effusionin
addit
confirm
patient
ident
verbal
note
site
procedur
follow
joint
commiss
identifi
critic
compon
timeout
univers
protocol
invas
procedur
patient
admit
diagnosisb
patient
date
birthc
type
procedur
patient
age
date
admission
followup
plan
procedur
answer
cthe
joint
commiss
defin
sever
critic
compon
timeout
effort
improv
patient
safeti
reduc
medic
error
compon
must
perform
prior
procedur
includ
confirm
patient
ident
site
procedur
type
procedur
referencea
followup
review
wrong
site
surgeri
sentinel
event
alert
follow
statement
fals
refer
urinari
tract
infect
asymptomat
bacteriuria
treat
patient
pregnantb
candiduria
may
repres
vagin
flora
colonizationc
urin
cultur
usual
posit
presenc
foley
cathet
treat
absenc
symptomsd
coloni
count
greater
requir
diagnos
uti
answer
ca
common
dilemma
necess
treat
asymptomat
bacteriuria
sever
situat
firstlin
antibiot
avoid
patient
nonimmunocompromis
posit
urin
cultur
necessit
antibiot
circumst
urin
cultur
usual
posit
presenc
foley
cathet
absenc
symptom
treat
treatment
deem
necessari
remov
foley
cathet
treat
total
day
treatment
either
bacteriuria
candiduria
foley
cathet
place
usual
ineffect
noth
increas
resist
microb
referencegould
cv
umscheid
ca
agarw
rk
kuntz
g
pegu
da
guidelin
prevent
catheterassoci
urinari
tract
infect
infect
control
hosp
epidemiol
prepar
discharg
retir
nurs
inpati
servic
hospit
heart
failur
two
admiss
year
patient
long
histori
hypertens
heart
failur
prior
admiss
report
weight
gain
peripher
edema
decreas
exercis
toler
day
hospit
patient
given
intraven
furosemid
mg
iv
bid
good
respons
admiss
medic
amlodipin
mg
daili
carvedilol
mg
twice
daili
furosemid
mg
daili
aspirin
mg
daili
suspect
compliant
medic
dieton
day
discharg
blood
pressur
mmhg
heart
rate
bpm
serum
sodium
meql
serum
creatinin
mgdl
electrocardiogram
demonstr
normal
sinu
rhythm
increas
voltag
precordi
lead
leftaxi
deviat
transthorac
echocardiogram
show
left
ventricular
eject
fraction
mildli
thicken
left
ventricl
enlarg
left
atriumwhich
follow
next
increas
amlodipin
dosag
mg
dailyb
increas
furosemid
dosag
mg
twice
dailyc
add
digoxin
mg
dailyd
add
lisinopril
mg
daily
increas
carvedilol
mg
twice
daili
answer
dthi
patient
respond
diuresi
may
need
intervent
prevent
exacerb
congest
heart
failur
heart
failur
normal
left
ventricl
eject
fraction
hfnef
preval
among
older
women
histori
hypertens
mainstay
treatment
includ
blood
pressur
manag
rate
control
lowsalt
diet
weight
loss
exercis
attempt
reinforceda
pair
observ
studi
demonstr
associ
discharg
prescript
angiotensinconvert
enzym
ace
inhibitor
lower
overal
mortal
among
patient
hfnef
patient
would
seem
reason
cautious
add
ace
inhibitor
increas
furosemid
dosag
might
exacerb
possibl
volum
deplet
referencesahm
rich
mw
zile
et
al
reninangiotensin
inhibit
diastol
heart
failur
chronic
kidney
diseas
j
med
patel
k
fonarow
gc
et
al
angiotensinconvert
enzym
inhibitor
outcom
heart
failur
preserv
eject
fraction
j
med
male
present
progress
short
breath
past
month
packyear
histori
smoke
ct
scan
chest
reveal
right
middl
lobe
mass
subsequ
undergo
biopsi
reveal
adenocarcinoma
magnet
reson
imag
brain
reveal
cm
tumor
left
cerebr
cortex
consist
metastat
diseas
patient
histori
seizur
syncop
patient
refer
outpati
therapi
hematologyoncolog
servic
well
followup
radiat
oncolog
patient
readi
dischargewhich
follow
would
appropri
therapi
primari
seizur
prevent
seizur
prophylaxi
indicatedb
valproatec
phenytoind
phenobarbital
oral
prednison
mg
daili
answer
ather
indic
antiepilept
therapi
primari
prevent
patient
brain
metastasi
undergon
resect
past
studi
reveal
differ
seizur
rate
placebo
antiepilept
therapi
patient
brain
tumor
antiepilept
therapi
high
rate
advers
reaction
caution
exercis
use
referencesirven
ji
wingerchuk
dm
drazkowski
jf
lyon
mk
zimmerman
rs
seizur
prophylaxi
patient
brain
tumor
metaanalysi
mayo
clin
proc
man
admit
dedic
geriatr
acut
care
unit
home
treatment
nausea
vomit
relat
urinari
tract
infect
unit
staf
limit
group
train
provid
outcom
geriatr
patient
assum
better
unitwhich
follow
statement
accur
character
benefit
geriatr
acut
care
unit
gener
inpati
ward
geriatr
acut
care
unit
reduc
inhospit
function
declineb
patient
receiv
care
geriatr
acut
care
unit
improv
function
statu
month
dischargec
geriatr
acut
care
unit
provid
patientcent
care
emphas
independenc
increas
likelihood
patient
receiv
care
geriatr
acut
care
unit
abl
return
home
upon
discharge
geriatr
acut
care
unit
provid
intens
review
medic
care
minim
advers
effect
medic
answer
abi
day
discharg
function
capac
geriatr
unit
nonspeci
acut
care
unitsgeriatr
unit
special
prepar
environ
specif
protocol
enhanc
discharg
plan
medic
care
design
minim
advers
effect
procedur
medic
geriatr
unit
one
sever
model
comprehens
inpati
geriatr
care
develop
geriatrician
research
address
advers
event
function
declin
often
accompani
hospitalizationdespit
assum
benefit
studi
far
mix
sever
shortterm
favor
outcom
record
includ
reduct
declin
shortterm
function
readmiss
longterm
endpoint
yet
demonstr
referencelandefeld
cs
palmer
rm
kresev
dm
fortinski
rh
kowal
j
random
trial
care
hospit
medic
unit
especi
design
improv
function
outcom
acut
ill
older
patient
n
engl
j
med
follow
bacteria
viru
like
etiolog
ventilatorassoci
pneumonia
vap
nurs
home
patient
medic
icu
congest
heart
failur
legionella
pneumoniab
e
coli
c
mycoplasma
pneumoniad
respiratori
syncyti
virus
staphylococcu
aureu
answer
edespit
geograph
variat
enterococcu
faecium
staphylococcu
aureu
klebsiella
pneumonia
acinetobact
baumannii
pseudomona
aeruginosa
enterobact
speci
eskap
pathogen
constitut
ventilatorassoci
pneumonia
vap
episod
organ
escap
biocid
action
mani
antibiot
develop
increas
resist
antibiot
develop
declin
resist
rise
healthcareassoci
infect
remain
constant
threat
patient
welfar
eskap
pathogen
increas
relev
antimicrobi
chemotherapi
come
year
referencespark
dr
microbiolog
ventilatorassoci
pneumonia
respir
care
rello
j
ventilatorassoci
pneumonia
caus
eskap
organ
caus
clinic
featur
manag
curr
opin
pulm
med
chain
reaction
pcr
bacteri
test
proven
assist
diagnosi
condit
communityacquir
pneumoniab
cellulitisc
endocarditisd
c
answer
epcr
bacteri
test
repres
major
advanc
rapid
diagnosi
infecti
diseas
may
use
blood
well
tissu
sampl
recent
studi
broadrang
pcr
assay
diagnos
infect
endocard
specif
sensit
posit
predict
valu
neg
predict
valu
situat
earli
diagnosi
benefici
antibiot
may
given
long
period
may
costeffect
far
pcr
shown
promis
diagnos
communityacquir
pneumonia
endocard
tissu
sampl
cost
pcr
test
decreas
use
anticip
referencesbarken
kb
haagensen
ja
tolkernielsen
advanc
nucleic
acidbas
diagnost
bacteri
infect
clin
chim
acta
k
logan
j
langham
swift
c
gharbia
util
realtim
amplif
select
rdna
sequenc
tool
detect
identif
microbi
signatur
directli
clinic
sampl
j
med
microbiol
name
literatur
contribut
higher
rate
readmiss
includ
differ
patient
health
statusb
discharg
plan
care
coordinationc
avail
effect
local
primari
care
threshold
admiss
area
lack
advanc
direct
answer
ealthough
implement
increas
use
advanc
direct
thought
effect
tool
decreas
readmiss
far
demonstr
signific
factor
reduc
readmiss
socioeconom
statu
comorbid
care
coordin
remain
signific
factor
determin
whether
patient
readmit
hospitalcar
transit
discharg
includ
coordin
followup
care
commun
patient
transfer
locat
level
care
time
medic
error
patient
harm
known
likelydu
increas
financi
incent
mani
studi
current
look
readmiss
prevent
strategi
yet
singl
factor
identifi
primari
factor
readmiss
prevent
referenceenguidano
vesper
e
lorenz
k
readmiss
among
serious
ill
older
adult
j
palliat
med
leonard
davi
school
gerontolog
lo
angel
univers
southern
california
follow
contraind
herp
zoster
vaccin
age
younger
yearsb
chronic
postherpet
neuralgiac
histori
shinglesd
lymphoma
histori
varicella
infect
answer
da
advisori
committe
immun
practic
acip
recommend
herp
zoster
vaccin
routin
recommend
adult
age
acip
state
peopl
primari
acquir
immunodefici
receiv
vaccin
immunodefici
state
lymphoma
aid
leukemia
constitut
absolut
contraind
receiv
herp
zoster
vaccineboth
center
diseas
control
prevent
acip
recommend
adult
vaccin
whether
report
previou
episod
herp
zosterther
remain
larg
popul
mildli
moder
immunocompromis
patient
riskbenefit
ratio
vaccin
well
understood
referencebrisson
pellissi
jm
camden
quach
c
de
wal
p
potenti
costeffect
vaccin
herp
zoster
postherpet
neuralgia
hum
vaccin
epub
may
man
evalu
hospit
patient
admit
yesterday
treatment
acut
pancreat
secondari
alcohol
abus
remain
symptomat
hon
physic
examin
lie
side
knee
drawn
chest
vital
sign
includ
temperatur
blood
pressur
mmhg
puls
rate
beatsmin
respiratori
rate
breathsmin
oxygen
satur
ambient
air
oral
mucosa
dri
abdomin
examin
disclos
decreas
bowel
sound
epigastr
tender
remaind
examin
normalleukocyt
count
hematocrit
blood
urea
nitrogen
mgdl
creatinin
mgdl
amylas
ulabdomin
ultrasonographi
show
gallston
dilat
common
bile
ductwhich
follow
predict
poor
outcom
patient
amylas
levelb
anemiac
blood
urea
nitrogen
leveld
leukocytosis
age
answer
chemoconcentr
measur
best
predictor
higher
morbid
mortal
patient
acut
pancreat
includ
elev
blood
urea
nitrogen
serum
creatinin
hematocrit
level
multipl
score
system
devis
measur
outcom
patient
acut
pancreat
tradit
util
ranson
criteria
reli
paramet
measur
admiss
h
acut
physiolog
chronic
health
evalu
ii
score
accur
ranson
criteriahemoconcentr
may
serv
marker
capillari
leak
acut
pancreat
may
explain
correl
mortal
patient
sever
diseas
tend
elev
level
blood
urea
nitrogen
serum
creatinin
hematocrit
factor
blood
urea
nitrogen
level
accur
predict
sever
factor
predispos
patient
poor
prognosi
medic
comorbid
age
greater
year
increas
bodymass
indexther
correl
degre
elev
serum
amylas
level
sever
prognosi
ill
patient
acut
pancreat
mild
moder
leukocytosi
common
patient
acut
pancreat
prognost
signific
referencetenn
bailli
j
dewitt
j
et
al
american
colleg
gastroenterolog
guidelin
manag
acut
pancreat
j
gastroenterol
follow
therapi
sever
acut
respiratori
distress
syndrom
ard
strongest
evid
improv
surviv
larg
random
studi
steroidsb
highfrequ
oscil
ventilationc
prone
positioningd
nebul
betaadrenerg
agonist
therapy
antibiot
prone
posit
may
improv
oxygen
patient
acut
respiratori
distress
syndrom
ard
sever
studi
examin
strategi
improv
outcom
ard
limit
posit
result
recent
larg
studi
patient
found
mark
reduct
patient
treat
prone
posit
complic
differ
two
treatment
except
higher
incid
cardiac
arrest
supin
patient
group
anoth
larg
random
trial
show
potenti
harm
increas
mortal
earli
use
highfrequ
oscil
ard
patient
ard
network
trial
nebul
betaadrenerg
agonist
therapi
fail
show
benefit
referencesferguson
nd
et
al
highfrequ
oscil
earli
acut
respiratori
distress
syndrom
n
engl
j
med
et
al
ardsnet
random
placebocontrol
clinic
trial
aerosol
treatment
acut
lung
injuri
j
respir
crit
care
med
hoo
gw
prone
ventil
one
good
turn
deserv
anoth
n
engl
j
med
white
male
past
medic
histori
diabet
present
emerg
room
chest
pain
admit
rule
myocardi
infarct
schedul
outpati
stress
testhi
lab
remark
increas
lipid
valu
particularli
ldl
discharg
inform
start
highintens
statin
follow
statin
correspond
dosag
regimen
consid
high
intens
rosuvastatin
mg
po
qhsb
pravastatin
mg
po
qhsc
simvastatin
mg
po
qhsd
atorvastatin
mg
po
qh
answer
datorvastatin
mg
daili
consid
highintens
statin
accord
current
guidelin
rosuvastatin
consid
high
intens
dose
mg
daili
pravastatin
mg
consid
low
intens
simvastatin
mg
daili
recommend
fda
due
increas
risk
myopathi
includ
rhabdomyolysi
referenceston
nj
robinson
j
lichtenstein
ah
et
al
accaha
guidelin
treatment
blood
cholesterol
reduc
atherosclerot
cardiovascular
risk
adult
report
american
colleg
cardiologyamerican
heart
associ
task
forc
practic
guidelin
j
coll
cardiol
male
admit
cellul
develop
within
past
day
develop
sudden
onset
chest
pain
h
ago
inspir
movement
exacerb
pain
patient
hemoptysi
histori
recent
surgeri
prolong
period
immobl
venou
thromboembol
cancerpuls
rate
beatsmin
respiratori
rate
breathsmin
blood
pressur
mmhg
oxygen
satur
room
air
patient
anxiou
alert
orient
person
place
time
physic
examin
show
abnorm
heart
lungson
laboratori
studi
cardiac
enzym
level
within
normal
limit
electrocardiographi
chest
xray
studi
show
abnormalitiesbas
well
criteria
follow
best
repres
probabl
pulmonari
embol
patient
lowb
intermediatec
highd
none
answer
athi
patient
low
well
criteria
probabl
pulmonari
embol
well
criteria
use
determin
pretest
probabl
pulmonari
embol
patient
base
histori
physic
examin
well
criteria
allow
clinician
determin
patient
need
diagnost
invas
testingth
well
criteria
assign
point
presenc
sign
symptom
histor
factor
includ
tachycardia
hemoptysi
deep
venou
thrombosi
addit
point
assign
histori
venou
thromboembol
activ
malign
recent
immobil
surgeri
well
criteria
assign
point
altern
diagnosi
like
patient
histor
factor
clinic
find
suggest
pulmonari
embol
well
score
symptom
could
relat
musculoskelet
pain
pleurisi
anxieti
referencewel
ps
anderson
dr
bormani
j
et
al
valu
assess
pretest
probabl
deepvein
thrombosi
clinic
manag
lancet
natriuret
factor
bnp
use
emerg
room
result
endpoint
decreas
admiss
ratesb
decreas
allcaus
mortalityc
decreas
length
stayd
decreas
readmissions
c
answer
ealthough
wide
measur
benefit
bnp
measur
clinic
qualiti
endpoint
remain
uncertain
metaanalysi
measur
effect
bnp
test
clinic
outcom
patient
present
emerg
depart
short
breath
reveal
bnp
test
led
decreas
admiss
rate
decreas
mean
length
stay
effect
allcaus
hospit
mortal
seenth
bnp
test
use
aid
diagnosi
assess
sever
heart
failur
bnp
test
also
use
risk
stratif
patient
acut
coronari
syndrom
bnp
valu
may
fluctuat
due
factor
heart
failur
lower
predict
level
often
seen
obes
patient
higher
level
seen
renal
diseas
absenc
heart
failureit
suggest
one
import
use
natriuret
peptid
help
establish
diagnosi
heart
failur
hf
diagnosi
uncertain
patient
valu
less
make
hf
unlik
valu
greater
make
hf
like
referenceslam
cameron
pa
schneider
hg
abramson
mj
c
krum
h
metaanalysi
effect
btype
natriuret
peptid
test
clinic
outcom
patient
acut
dyspnea
emerg
set
ann
intern
med
mueller
c
adam
k
jr
et
al
state
art
use
natriuret
peptid
level
clinic
practic
eur
j
heart
fail
femal
admit
nurs
home
diagnosi
urinari
tract
infect
sepsi
histori
progress
dementia
known
implant
devic
orthoped
intern
hardwareblood
cultur
drawn
reveal
gramposit
rod
otherwis
sourc
infect
isol
urin
cultur
neg
first
h
clinic
improv
back
baselin
mental
statuswhich
follow
explain
posit
blood
cultur
urinari
tract
infectionb
endocarditisc
skin
contaminationd
chronic
wound
infect
answer
cthere
four
bacteria
common
contamin
blood
cultur
posit
coagulaseneg
staph
gramposit
cocci
corynebacterium
gramposit
rod
propionibacterium
acn
anaerob
gramposit
rod
bacillu
speci
anaerob
gramposit
rod
may
consid
true
pathogen
multipl
site
posit
patient
prosthet
implant
staphylococcu
aureu
streptococcu
speci
enterococcu
candida
pseudomona
gramneg
rodsposit
bacillu
usual
contamin
skin
particular
case
without
sign
overwhelm
sepsi
gramposit
rod
almost
certainli
contamin
referencemadeo
barlow
g
reduc
bloodcultur
contamin
rate
use
chlorhexidin
solut
applic
acut
admiss
unit
j
hosp
infect
caucasian
femal
past
medic
histori
diabet
osteoarthr
admit
right
hip
total
arthroplasti
periop
receiv
subcutan
enoxaparin
anticoagul
therapi
hip
fractur
servic
manag
hospit
medicin
call
see
day
three
suddenonset
substern
chest
pain
minim
respons
two
dose
sublingu
nitroglycerin
initi
ekg
demonstr
inferior
lead
st
elev
stat
lab
drawn
reveal
elev
troponin
ngml
complet
blood
count
show
platelet
count
cellsmcl
cellsmcl
time
admissionwhich
drug
fda
approv
indic
manag
acut
coronari
syndrom
patient
oral
lepirudinb
oral
rivaroxabanc
intraven
enoxaparind
bivalirudin
fondaparinux
answer
dthi
patient
develop
heparininduc
thrombocytopenia
hit
acut
stemi
bivalirudin
direct
thrombin
inhibitor
fda
approv
manag
patient
acut
stemi
secondari
risk
hit
enoxaparin
avoid
patient
hit
although
fondaparinux
lepirudin
use
acut
coronari
syndrom
ac
indic
patient
develop
ac
hit
referencebittl
ja
chaitman
br
feit
f
et
al
bivalirudin
versu
heparin
coronari
angioplasti
unstabl
postinfarct
angina
final
report
reanalysi
bivalirudin
angioplasti
studi
heart
j
provid
follow
benefit
elderli
patient
congest
heart
failur
preserv
eject
fraction
decreas
allcaus
mortalityb
decreas
heart
failur
rehospitalizationc
abov
none
answer
dbetablock
essenti
treatment
chf
reduc
eject
fraction
howev
patient
chf
preserv
eject
fraction
benefit
demonstr
studi
year
patient
age
associ
individu
endpoint
allcaus
mortal
heart
failur
rehospit
use
betablock
discharg
referencepatel
k
et
al
betablock
older
patient
heart
failur
preserv
eject
fraction
class
dosag
outcom
int
j
cardiol
follow
common
type
prevent
advers
event
hospit
patient
advers
drug
eventsb
diagnost
failuresc
fallsd
technic
complic
procedures
wound
infect
answer
ath
common
advers
event
hospit
patient
advers
drug
event
ade
occur
approxim
hospit
advers
event
defin
injuri
caus
medic
manag
rather
underli
diseas
patientin
recent
year
increas
focu
safeti
health
care
provid
throughout
world
institut
medicin
report
identifi
safeti
essenti
compon
qualiti
health
care
one
largest
studi
attempt
quantifi
advers
event
hospit
patient
harvard
medic
practic
studi
studi
advers
event
includ
ade
wound
infect
technic
complic
procedur
diagnost
mishap
fall
round
pharmacist
shown
greatli
reduc
prevent
advers
drug
event
one
studi
fewer
prevent
advers
drug
event
ade
occur
among
patient
pharmacist
particip
weekday
medic
round
referenceskrahenbuhlmelch
schlienger
r
lampert
et
al
drugrel
problem
hospit
review
recent
literatur
drug
saf
sn
peter
mlynarek
et
al
pharmacist
round
team
reduc
prevent
advers
drug
event
hospit
gener
medicin
unit
arch
intern
med
common
precipit
trigger
type
hepatoren
syndrom
sepsisb
largevolum
paracentesisc
renal
toxic
drugsd
increas
diuret
dose
spontan
bacteri
peritonitisf
urinari
tract
infect
answer
eth
hepatoren
syndrom
hr
develop
spontan
trigger
precipit
event
type
hr
character
rapidli
progress
kidney
failur
doubl
serum
creatinin
level
greater
mgdl
halv
creatinin
clearanc
less
mlmin
period
less
week
common
precipit
trigger
type
hepatoren
hr
syndrom
spontan
bacteri
periton
consid
endstag
liver
diseas
esld
patient
hepatoren
syndrom
import
consid
even
absenc
symptomstyp
hr
occur
approxim
patient
sbp
despit
rapid
resolut
infect
antibioticshepatoren
syndrom
primarili
induc
renal
arteri
vasoconstrict
sever
condit
decreas
renal
blood
flow
also
induc
type
hepatoren
syndrom
includ
sepsi
volum
deplet
volum
shift
may
occur
largevolum
paracentesi
undertaken
adequ
plasma
expans
undertaken
largevolum
paracentesi
occur
referencebetrosian
ap
agarw
b
douzina
ee
acut
renal
dysfunct
liver
diseas
world
j
gastroenterol
femal
admit
hospit
medicin
servic
possibl
osteomyel
past
medic
histori
includ
hypertens
diabet
mellitu
type
depress
hyperlipidemialab
within
normal
limit
except
elev
wbc
count
medic
admiss
order
complet
emerg
room
physician
order
pantoprazol
mg
po
daili
stress
ulcer
prophylaxisi
pantoprazol
indic
patient
yesb
answer
bprophylact
proton
pump
inhibitor
therapi
recommend
follow
major
risk
factor
respiratori
failur
requir
mechan
ventil
like
greater
h
coagulopathi
defin
platelet
count
inr
ptt
control
prophylact
treatment
dose
anticoagul
constitut
coagulopathi
addit
risk
factor
warrant
stress
ulcer
prophylaxi
follow
head
spinal
cord
injuri
sever
burn
bsa
acut
organ
dysfunct
histori
gi
ulcerbleed
within
year
high
dose
corticosteroid
liver
failur
associ
coagulopathi
postop
transplant
acut
kidney
injuri
major
surgeri
multipl
traumasuppress
acid
product
stomach
may
lead
advers
side
effect
increas
risk
aspir
pneumonia
referencesashp
commiss
therapeut
ashp
therapeut
guidelin
stress
ulcer
prophylaxi
j
health
syst
pharm
jm
stressrel
mucos
diseas
intens
care
unit
updat
prophylaxi
aacn
adv
crit
care
unit
medic
director
ask
hospit
administr
align
current
cardiac
code
polici
evidencebas
guidelin
particular
ask
reduc
variabl
current
occurswhich
follow
would
suggest
increas
frequenc
advanc
cardiovascular
life
support
acl
train
becom
annual
requir
clinic
practitionersb
interview
hospit
staff
use
delphi
method
process
enumer
optim
resuscit
practicesc
develop
resuscitationspecif
privileg
requir
hospit
credentialedd
implement
american
heart
associ
aha
get
guidelin
resuscit
program
answer
dthe
american
heart
associ
aha
put
great
deal
effort
expertis
develop
evidencebas
guidelin
cardiac
resuscitationth
aha
get
guidelin
program
develop
identifi
improv
opportun
allow
perform
comparison
among
hospit
reduc
medic
error
datadriven
peer
review
aha
review
uptod
research
scientif
public
develop
program
program
includ
guidelin
resuscit
atrial
fibril
heart
failur
stroke
referenceamerican
heart
associ
aha
get
guidelin
resuscit
program
http
wwwheartorgheartorghealthcareresearchgetwiththeguidelineshfstrokegetwiththeguidelinesstrokehomepagegetwithguidelinesstrokeoverview
access
dec
us
govern
nation
qualiti
forumapprov
methodolog
calcul
excess
readmiss
rate
includ
follow
except
adjust
clinic
relev
patient
comorbiditiesb
patient
socioeconom
statu
specif
feder
defin
incom
level
poverti
linec
establish
period
discharg
calculatedd
readmiss
caus
anoth
hospit
patient
specifi
diagnoses
minimum
number
case
annual
hospit
list
answer
bthirtyday
hospit
readmiss
common
costli
may
signal
unnecessari
use
resourc
focu
us
health
polici
intervent
reduc
costin
march
comprehens
health
reform
act
patient
protect
afford
care
act
went
law
law
establish
program
encourag
reduct
hospit
readmiss
requir
us
center
medicar
medicaid
servic
reduc
payment
hospit
excess
readmissionsthirtyday
hospit
readmiss
calcul
consid
socioeconom
statu
race
ethnic
english
languag
profici
risk
adjust
strong
risk
factor
readmiss
hospit
advoc
feel
factor
clinician
control
consid
penalti
determin
referencecmsgov
readmiss
reduct
program
wwwcmsgovmedicaremedicarefeefor
servicepaymentacuteinpatientppsreadmissionsreductionprogramhtml
access
nov
follow
statement
true
compar
dopamin
norepinephrin
firstlin
vasotherapi
septic
shock
increas
overal
death
rateb
increas
death
rate
among
septic
shock
groupc
increas
arrhythmiasd
increas
use
addit
vasopressor
answer
calthough
longstand
debat
singl
vasopressor
definit
shown
mortal
benefit
anoth
patient
septic
shock
help
better
answer
question
whether
mortal
benefit
initi
vasopressor
use
sepsi
occurr
acut
ill
patient
ii
soap
ii
studi
random
patient
shock
norepinephrin
dopamin
initi
vasopressor
studi
found
differ
two
group
mortal
although
significantli
cardiac
arrhythmia
dopamin
group
referenceshavel
c
arrich
j
losert
h
gamper
g
herkner
h
vasopressor
hypotens
shock
cochran
databas
syst
rev
pe
mohedin
contrast
effect
dopamin
norepinephrin
system
splanchnic
oxygen
util
hyperdynam
sepsi
jama
femal
present
confus
diaphoresi
mild
short
breath
rapidli
perform
ekg
reveal
possibl
ischemiath
common
symptom
acut
myocardi
infarct
patient
older
year
old
chest
painb
alter
mental
statusc
syncop
dyspnea
fever
answer
din
patient
older
year
age
short
breath
common
symptom
myocardi
infarct
may
due
acut
congest
heart
failur
anxieti
elderli
diabet
femal
patient
often
atyp
angin
symptom
initi
evalu
elderli
patient
suspect
myocardi
ischemia
begin
high
index
suspicion
atyp
symptom
referencesaronow
ws
epstein
use
silent
ischemia
ventricular
tachycardia
complex
ventricular
arrhythmia
predict
new
coronari
event
elderli
patient
coronari
arteri
diseas
system
hypertens
j
cardiol
r
clement
wingo
et
al
acut
heart
failur
elderli
anoth
manifest
unstabl
angina
j
coll
cardiol
antibiot
may
associ
greatest
odd
ventricular
arrhythmia
cardiovascular
death
adult
patient
levofloxacinb
azithromycinc
moxifloxacind
clarithromycin
clindamycin
answer
bthere
concern
azithromycin
may
increas
risk
ventricular
arrhythmia
suscept
adult
databas
analysi
found
increas
arrhythmia
cardiovascular
event
patient
treat
azithromycin
found
associ
clarithromycin
ciprofloxacin
advers
cardiac
outcomesmani
author
suggest
older
individu
high
risk
cardiovascular
diseas
may
vulner
advers
effect
use
extra
caution
take
antibioticit
also
suggest
inappropri
use
led
widespread
antibiot
resist
contribut
emerg
resist
bacteriaazithromycin
develop
market
unit
state
sinc
commonli
prescrib
antibiot
referencesbril
f
gonzalez
cd
di
girolamo
g
antimicrobi
agentsassoci
qt
interv
prolong
curr
drug
saf
wa
murray
kt
hall
k
arbogast
pg
stein
cm
azithromycin
risk
cardiovascular
death
n
engl
j
med
male
admit
prior
morn
suspect
mening
blood
cultur
done
emerg
room
reveal
neisseria
meningitidi
patient
start
h
ago
vancomycin
ceftriaxon
patient
current
afebril
neck
stiff
photophobia
decreasedwhen
appropri
time
remov
patient
isol
discontinu
nowb
h
follow
admissionc
h
antibiot
startedd
upon
complet
resolut
clinic
symptoms
upon
discharg
answer
cfor
case
bacteri
mening
isol
discontinu
h
initi
antibiot
import
remov
isol
safe
done
reduc
psycholog
stress
place
patient
improv
patient
care
facilit
discharg
plan
referencechaudhuri
p
martin
pm
et
al
efn
guidelin
manag
communityacquir
bacteri
mening
report
efn
task
forc
acut
bacteri
mening
older
children
adult
eur
j
neurol
pharmaceut
compani
publish
inconclus
result
new
drug
market
exampl
report
biasb
underestimationc
cofoundingd
none
answer
areport
bia
continu
major
problem
assess
healthcar
intervent
sever
promin
case
report
public
bia
describ
literatur
includ
trial
report
effect
antidepress
class
antiarrhythm
drug
select
inhibitor
studi
drug
shown
ineffect
often
publish
delay
modifi
emphas
posit
result
suggestedin
addit
trial
statist
signific
find
gener
publish
academ
journal
higher
circul
often
trial
nonsignific
find
gener
publish
evid
tend
overestim
efficaci
underestim
safeti
risk
extent
often
unknown
referencesmacauley
reader
acronym
aid
critic
read
gener
practition
br
j
gen
pract
j
egger
moher
address
report
bias
higgin
jpt
green
editor
cochran
handbook
systemat
review
intervent
chichest
wiley
p
central
venou
cathet
cvc
peripher
insert
central
cathet
picc
associ
follow
lower
patient
satisfactionb
lower
costeffectivenessc
greater
risk
bloodstream
infectiond
greater
risk
deep
vein
thrombosi
answer
dpicc
mani
advantag
central
venou
cathet
picc
reliabl
altern
shortterm
central
venou
cathet
lower
risk
complic
picc
higher
patient
satisfact
lower
infect
rate
costeffect
cvcshowev
picc
associ
higher
risk
deep
vein
thrombosi
central
venou
cathet
cvc
risk
increas
patient
critic
ill
malign
also
meet
definit
picc
distal
tip
cathet
must
termin
superior
vena
cava
inferior
vena
cava
proxim
right
atrium
thrombosi
may
result
picc
insert
peripher
vein
narrow
like
occlud
presenc
cathet
larg
vein
use
cvc
referencechopra
v
anand
hickner
et
al
risk
venou
thromboembol
associ
peripher
insert
central
cathet
systemat
review
metaanalysi
lancet
hospit
readmiss
rate
patient
unit
state
medicar
dischargesb
medicar
dischargesc
hospit
patient
cover
commerci
payersd
medicar
commerci
payers
none
answer
medicar
beneficiari
discharg
hospit
rehospit
within
day
rehospit
within
day
sinc
time
small
reduct
readmiss
occurredreduc
readmiss
rate
major
prioriti
hospit
given
afford
care
act
aca
establish
hospit
readmiss
reduct
program
requir
center
medicar
medicaid
servic
cm
reduc
payment
hospit
excess
readmissionsnot
readmiss
avoid
unplan
readmiss
frequent
suggest
breakdown
continu
care
unsuccess
transit
care
set
studi
suggest
readmiss
usual
tie
medic
error
commit
hospit
stay
rather
social
issu
poor
followup
patient
lack
understand
posthospit
carereduc
readmiss
proven
difficult
simpl
fix
found
gain
seen
institut
employ
multifactori
approach
referencejenck
sf
william
mv
coleman
ea
rehospit
among
patient
medicar
feeforservic
program
n
engl
j
med
man
present
pain
swell
right
knee
swell
sever
finger
otherwis
healthi
recal
sever
bout
diarrheal
ill
week
prior
spontan
resolv
take
medic
report
rare
marijuana
useon
physic
exam
limit
motion
swell
right
knee
suspect
reactiv
arthriti
due
diarrheal
illnesswhich
follow
like
etiolog
agent
diarrhea
campylobact
jejuni
b
clostridium
difficil
c
escherichia
coli
helicobact
pylori
e
shigella
flexneri
answer
eth
common
organ
associ
reactiv
arthriti
diarrheal
ill
shigella
speci
reactiv
arthriti
refer
acut
nonpurul
arthriti
occur
infect
elsewher
bodi
shigella
infect
often
present
lower
joint
inflammatori
arthriti
occur
week
diarrheal
episod
reactiv
arthriti
may
also
includ
uveiti
conjunct
dactyl
urogenit
lesion
occur
yersinia
chlamydia
much
lesser
extent
salmonella
campylobact
referencehannu
mattila
l
siitonen
leirisalorepo
reactiv
arthriti
attribut
shigella
infect
clinic
epidemiolog
nationwid
studi
ann
rheum
di
nurs
home
resid
admit
melena
call
see
first
night
found
unrespons
bed
immers
black
stool
past
medic
histori
remark
alzheim
dementiaon
physic
pressur
mmhg
heart
rate
beatsmin
transfer
icu
central
venou
cathet
place
reveal
cvp
less
mmhg
catheter
bladder
yield
urin
anesthesiolog
call
bedsid
assess
patient
airwayin
patient
describ
follow
true
regard
clinic
condit
loss
blood
volum
lead
shock
physiologyb
loss
less
blood
volum
manifest
orthostasisc
oliguria
prognost
sign
impend
vascular
collaps
symptom
hypovolem
shock
differ
hemorrhag
shock
first
sign
hypovolem
shock
mental
obtund
answer
coliguria
import
clinic
paramet
help
guid
volum
resuscit
volum
resuscit
initi
rapid
iv
infus
isoton
salin
ringer
lactat
assess
adequ
airway
spontan
breath
initi
resuscit
aim
reexpand
intravascular
volum
control
ongo
loss
transfus
pack
red
blood
cell
prbc
consid
hemorrhag
shock
continu
blood
loss
hemoglobin
less
gdlsymptom
hemorrhag
nonhemorrhag
shock
indistinguish
blood
volum
lost
clinic
symptom
except
mild
tachycardia
orthostasi
seen
loss
blood
volum
shock
occur
loss
blood
volum
result
mark
tachycardia
hypotens
oliguria
final
obtund
central
nervou
system
perfus
maintain
shock
becom
severeonc
hemorrhag
control
transfus
prbc
perform
hemoglobin
gdl
less
patient
remain
hypotens
volum
resuscit
poor
prognosi
inotrop
support
intens
monitor
initi
patient
referencestainsbi
maclennan
thoma
isaac
j
hamilton
pj
guidelin
manag
massiv
blood
loss
br
j
haematol
follow
circumst
would
albumin
infus
benefici
patient
endstag
liver
diseas
ascit
requir
paracentesisb
patient
hypotens
serum
albumin
gdlc
patient
acut
blood
loss
await
type
match
pack
red
blood
cell
infusiond
patient
hypotens
sepsi
syndrom
serum
albumin
gdl
answer
ath
role
albumin
infus
remain
uncertain
mani
clinic
situat
albumin
compos
blood
plasma
protein
effect
prevent
complic
highvolum
paracentesi
patient
cirrhosi
ascit
undergo
paracentesi
indic
use
albumin
administr
critic
ill
patient
uncertain
gener
albumin
given
specif
treat
hypoalbuminemia
marker
seriou
diseas
referencemcgibbon
chen
gi
peltekian
km
van
zanten
sv
evidencebas
manual
abdomin
paracentesi
dig
di
sci
patient
greater
year
age
hospit
heart
failur
preserv
eject
fraction
discharg
new
prescript
calcium
channel
blocker
ccb
provid
benefit
decreas
mortalityb
decreas
heart
failur
admissionsc
decreas
incid
myocardi
infarctiond
none
answer
dnew
discharg
prescript
ccb
correl
improv
endpoint
older
patient
hospit
hf
eject
fraction
accord
studi
referencepatel
k
et
al
calciumchannel
blocker
outcom
older
patient
heart
failur
preserv
eject
fraction
circ
heart
fail
white
femal
present
confus
known
histori
alcohol
ascit
hepat
encephalopathi
ammonia
upon
admiss
elev
husband
claim
take
lactulos
often
prescrib
also
report
bowel
movement
per
day
upon
admiss
lactulos
restart
g
po
tid
day
hospit
patient
alert
closer
baselin
per
husband
nurs
chart
follow
bowel
movement
day
day
day
far
lactulos
work
set
hepat
encephalopathi
decreas
amount
ammoniaproduc
bacteria
gutb
creat
acid
ph
gut
turn
caus
becom
result
osmot
effect
gut
due
nonabsorb
ammonium
ionc
creat
resin
ammonia
bind
excret
fecallyd
work
stimul
lax
answer
boption
describ
mechan
action
rifaximin
option
c
incorrect
resin
form
lactulos
option
incorrect
lactulos
work
osmot
rather
stimul
referencealsnielsen
b
gluud
gluud
c
nonabsorb
disaccharid
hepat
encephalopathi
systemat
review
randomis
trial
bmj
man
admit
cellul
respond
antibiot
readi
discharg
would
like
get
warfarin
start
six
month
ago
atrial
fibril
underw
ablat
month
ago
longstand
atrial
fibril
symptom
palpit
sinc
hypertens
type
diabet
mellitu
medic
lisinopril
atenolol
insulin
warfarinblood
pressur
mmhg
puls
rate
beatsmin
cardiac
examin
ekg
disclos
regular
rate
rhythm
rest
physic
examin
normalwhich
follow
appropri
treatment
continu
warfarinb
switch
aspirinc
switch
clopidogreld
switch
aspirin
clopidogrel
h
halter
monitor
answer
awarfarin
continu
indefinit
patient
patient
atrial
fibril
ablat
take
warfarin
month
best
manag
strategi
provid
anticoagul
ablat
occur
tool
score
commonli
use
guid
therapi
option
although
patient
symptom
atrial
fibril
sinc
ablat
procedur
warfarin
still
indicatedhypertens
diabet
mellitu
give
patient
score
two
risk
stroke
per
year
score
zero
aspirin
alon
prefer
agent
new
agent
dabigatran
rivaroxaban
may
option
agent
studi
postatri
fibril
ablat
set
referenceouyang
f
tilz
r
chun
j
schmidt
b
wissner
e
zerm
neven
k
b
konstantinid
metzner
fuernkranz
kuck
kh
longterm
result
cathet
ablat
paroxysm
atrial
fibril
lesson
followup
circul
woman
present
emerg
room
complaint
fever
diarrhea
nausea
vomit
recent
return
africa
spend
month
medic
mission
emerg
isol
procedur
activ
remain
ill
develop
worsen
symptom
odynophagia
sore
throat
conjunct
diagnos
ebola
viru
final
develop
dissemin
intravascular
coagul
mucos
bleed
alter
mental
statu
anuria
die
day
later
emerg
room
nurs
may
expos
patient
bodili
fluidshow
long
nurs
follow
sign
ebola
infect
daysb
daysc
daysd
day
answer
bthe
center
diseas
control
prevent
recommend
peopl
possibl
ebola
exposur
receiv
medic
evalu
close
followup
care
includ
fever
monitor
twice
daili
day
last
known
exposurecontact
trace
shown
effect
case
follow
day
exposur
effect
limit
outbreak
worldwid
rural
area
move
expos
patient
symptom
home
commun
design
area
isol
also
proven
success
control
effort
suggest
expos
health
care
personnel
medic
follow
day
sign
symptom
ebola
viru
referenceswest
te
von
saint
arnim
clinic
present
manag
sever
ebola
viru
diseas
ann
thorac
soc
health
organ
ebola
respons
team
ebola
viru
diseas
west
first
month
epidem
forward
project
n
engl
j
med
admit
communityacquir
pneumonia
statin
follow
characterist
decreas
inhospit
deathb
decreas
need
mechan
ventilationc
decreas
acut
respiratori
failur
decreas
icu
admission
answer
eregular
statin
use
may
significantli
associ
favor
outcom
admiss
communityacquir
pneumonia
addit
statin
may
benefici
effect
clinic
cours
sever
infecti
diseas
includ
bacteri
sepsi
anim
human
protect
benefit
statin
presum
relat
antiinflammatori
immunomodulatori
activ
investig
even
suggest
statin
might
use
treatment
prophylaxi
pandem
influenza
referenceschung
sd
et
al
statin
use
clinic
outcom
among
pneumonia
patient
clin
microbiol
infect
ds
pandem
influenza
potenti
role
statin
treatment
prophylaxi
clin
infect
di
review
avail
studi
effect
start
alpha
blocker
prior
remov
urinari
cathet
order
prevent
retent
reduc
urinari
retentionb
increas
side
effect
compar
placeboc
increas
success
rate
cathet
removald
prevent
longterm
urinari
retention
better
placebo
cathet
remov
success
rate
answer
cthe
limit
avail
evid
suggest
alpha
blocker
increas
success
rate
cathet
remov
highrisk
patient
fortun
alpha
blocker
side
effect
low
compar
placebo
uncertain
whether
alpha
blocker
reduc
risk
recurr
urinari
retent
costeffect
recommend
durat
alpha
blocker
treatment
remain
unknown
alpha
blocker
prior
remov
cathet
acut
urinari
retent
adult
men
caus
vasodilatationrel
side
effect
referencezeif
hj
subramonian
k
alpha
blocker
prior
remov
cathet
acut
urinari
retent
adult
men
cochran
databas
syst
rev
follow
patient
group
would
adequ
treat
pneumonia
util
ceftriaxon
azithromycin
therapi
upon
present
emerg
depart
femal
attend
dialysi
tuesday
thursday
saturdayb
male
undergo
chemotherapi
acut
leukemiac
femal
histori
hypertens
glaucoma
never
hospitalizedd
male
resid
nurs
home
due
earlyonset
dementia
answer
cthe
major
hospit
patient
communityacquir
pneumonia
treat
either
respiratori
fluoroquinolon
combin
cephalosporin
macrolid
current
durat
treatment
recommend
total
therapi
cours
import
physician
assess
patient
increas
risk
bacteri
resist
empir
antibiot
regimen
patient
meet
criteria
healthcareassoci
pneumonia
identifi
antibiot
regimen
may
need
includ
coverag
methicillinresist
staphylococcu
aureu
mrsa
multidrugresist
mdr
gramneg
pathogenscriteria
healthcareassoci
pneumonia
hospit
day
previou
daysdevelop
pneumonia
greater
h
postadmiss
hospitalresid
nurs
home
extendedcar
facilitylongterm
use
infus
therapi
home
includ
antibioticshemodialysi
previou
dayshom
wound
carefamili
member
multidrugresist
pathogenimmunosuppress
diseas
therapi
organ
transplant
activ
chemotherapi
referencesolomon
c
communityacquir
pneumonia
n
engl
j
med
commonli
use
illeg
substanc
urban
set
cocaineb
marijuanac
prescript
opioidsd
nonpresript
opioids
amphetamin
answer
bmarijuana
commonli
use
illeg
substanc
follow
cocain
opioid
prescript
opioid
marijuana
use
remain
stabl
even
though
percentag
peopl
describ
drug
harm
went
illicit
drug
use
gener
declin
past
two
decadesmarijuana
legal
unit
state
congress
pass
marijuana
tax
act
effect
make
drug
illeg
referencewilkinson
st
souza
dc
problem
medic
marijuana
jama
man
admit
nurs
home
stroke
week
ago
patient
residu
rightsid
paralysi
aphasia
urinari
incontin
respond
verbal
command
speak
well
enough
make
need
known
spend
day
bed
chair
expect
physic
progress
slow
need
assist
activ
daili
live
patient
poor
appetit
use
right
arm
feed
eat
half
meal
also
intermitt
urinari
incontin
current
skin
breakdownwhich
follow
appropri
intervent
prevent
pressur
ulcer
patient
airfluid
bedb
doughnut
cushion
seatedc
foam
mattress
overlayd
bladder
catheterization
massag
skin
pressur
answer
cthi
patient
mani
risk
factor
pressur
ulcer
includ
advanc
age
reduc
mobil
poor
nutrit
urinari
incontin
appropri
costeffect
prevent
measur
patient
foam
mattress
overlay
systemat
review
conclud
special
foam
mattress
overlay
special
sheepskin
overlay
reduc
incid
pressur
ulcer
compar
standard
mattressessinc
limit
prevent
approach
pressur
ulcer
less
costli
one
focus
treat
establish
ulcer
patient
identifi
quickli
possiblewheth
addit
advantag
ulcer
prevent
use
expens
airfluid
bed
unclear
bed
make
nurs
care
difficult
usual
reserv
treat
patient
establish
extens
ulcersth
prefer
seat
cushion
one
distribut
pressur
uniformli
weightbear
bodi
surfac
doughnut
cushion
use
prevent
measurean
indwel
condom
cathet
sometim
need
treat
stage
iv
ulcer
use
caution
referencepham
b
teagu
l
mahoney
j
goodman
l
paulden
poss
j
et
al
earli
prevent
pressur
ulcer
among
elderli
patient
admit
emerg
depart
costeffect
analysi
ann
emerg
med
ask
see
male
emerg
depart
histori
cough
increas
short
breath
enjoy
good
health
medicationson
physic
examin
temperatur
blood
pressur
crackl
note
right
lower
lung
field
remaind
physic
examin
normallaboratori
data
reveal
hemoglobin
leukocyt
count
blood
urea
nitrogen
mgdl
creatinin
mgdl
glucos
chest
xray
reveal
right
lower
lobe
infiltr
blood
cultur
sputum
gram
stain
pendingwhich
follow
appropri
manag
patient
begin
empir
antibiot
admit
intens
care
unitb
begin
empir
antibiot
admit
medic
wardc
discharg
oral
antibiot
therapyd
administ
singl
dose
empir
antibiot
discharg
oral
antibiot
therapi
answer
bthe
correct
level
care
patient
includ
admit
medic
ward
intraven
antibiot
score
estim
mortal
risk
base
upon
follow
indic
confus
blood
urea
nitrogen
level
respiratori
rate
per
minut
systol
blood
pressur
diastol
pressur
age
year
older
one
point
score
posit
indic
patient
score
low
mortal
risk
consid
outpati
treatment
score
hospit
patient
score
consid
admiss
intens
care
unit
patient
score
predict
mortal
risk
hospit
recommend
patient
score
higherth
compar
complic
pneumonia
sever
index
psi
predict
mortal
pneumonia
shown
psi
better
predictor
shortterm
mortal
referencehowel
md
donnino
mw
talmor
clardi
p
ngo
l
shapiro
ni
perform
sever
ill
score
system
emerg
depart
patient
infect
acad
emerg
med
hospit
initi
perform
improv
plan
decreas
rate
catheterassoci
urinari
tract
infect
follow
patient
current
meet
indic
indwel
urinari
cathet
usag
male
prostat
cancer
urin
day
cc
urin
present
bladder
scanb
femal
unabl
use
bedsid
commod
request
foley
cathet
hospitalc
man
urinari
incontin
stage
sacral
ulcerd
above
cf
b
c
answer
esom
accept
indic
indwel
urinari
cathet
includ
follow
clinic
signific
urinari
retent
temporari
relieffor
comfort
termin
ill
patientaccur
urin
output
monitor
critic
ill
patientdur
prolong
surgic
procedur
gener
spinal
anesthesiato
aid
heal
stage
sacral
decubitu
ulcer
fail
treatment
worsen
due
urinari
incontin
patient
prefer
urinari
incontin
monitor
urinari
output
stabl
patient
indic
indwel
urinari
cathet
avoid
referencehooton
tm
bradley
sf
cardena
dd
colgan
r
geerl
se
rice
jc
saint
schaeffer
aj
tambayh
pa
tenk
p
nicol
le
infecti
diseas
societi
america
diagnosi
prevent
treatment
catheterassoci
urinari
tract
infect
adult
intern
clinic
practic
guidelin
infecti
diseas
societi
america
clin
infect
di
woman
admit
stroke
unit
newonset
left
hemiparesi
leftsid
neglect
ct
scan
head
show
right
middl
cerebr
arteri
infarct
mri
done
h
present
show
intralumin
thrombu
consist
intern
carotid
arteri
dissectionon
physic
examin
day
admiss
temperatur
normal
blood
pressur
mmhg
puls
rate
beatsmin
respiratori
rate
breathsmin
cardiopulmonari
examin
normal
letharg
famili
report
depress
dysarthria
left
arm
leg
weak
upper
airway
congest
note
bedsid
dysphagia
screen
unabl
safe
swallow
water
mild
coughwhich
follow
appropri
next
step
manag
earli
rehabilitationb
amoxicillinc
modafinild
stent
intern
carotid
paroxetin
answer
arehabilit
initi
patient
soon
medic
stabl
acut
ischem
stroke
identifi
caus
result
signific
motor
dysfunctionearli
rehabilit
multipl
benefici
effect
stroke
recoveri
physic
therapi
may
prevent
risk
deep
venou
thrombosi
atelectasi
contractur
skin
breakdown
evalu
speech
swallow
therapist
abil
swallow
liquid
safe
step
improv
stroke
recoveri
includ
screen
treat
poststrok
depress
minim
occurr
poststrok
medic
complic
pneumonia
urinari
tract
infectionsprophylact
antibiot
stroke
patient
risk
aspir
shown
effect
reduc
incid
pneumoniath
central
nervou
system
stimul
modafinil
unlik
help
patient
earli
recoveri
gener
pharmacolog
agent
includ
amphetamin
antidepress
indic
acut
phase
yet
shown
improv
stroke
recoveryst
intern
carotid
arteri
indic
patient
experienc
recurr
symptom
indic
stent
set
carotid
arteri
dissect
known
referencesjauch
ec
saver
jl
adam
hp
jr
bruno
connor
jj
demaerschalk
bm
khatri
p
mcmullan
pw
jr
qureshi
ai
rosenfield
k
scott
pa
summer
dr
wang
dz
wintermark
yona
h
american
heart
associ
stroke
council
council
cardiovascular
nurs
council
peripher
vascular
diseas
council
clinic
cardiolog
guidelin
earli
manag
patient
acut
ischem
stroke
guidelin
healthcar
profession
american
heart
associationamerican
stroke
associ
stroke
follow
best
describ
plandostudyact
pdsa
cycl
qualiti
improv
health
care
pdsa
obviat
need
perform
measurementb
pdsa
activ
requir
approv
institut
review
boardc
random
control
trial
greater
validityd
pdsa
describ
process
measur
effect
chang
answer
dpdsa
cycl
form
part
improv
guid
provid
framework
develop
test
implement
chang
lead
improv
commonli
use
healthcar
set
emphas
measur
taken
implement
chang
call
measur
built
process
discourag
chang
without
measurementth
model
base
scientif
method
moder
desir
take
immedi
action
insist
care
studi
qualiti
improv
activ
requir
approv
institut
review
board
referencescurti
jr
levi
mm
improv
scienc
polit
qualiti
improv
jama
e
laupaci
pronovost
pj
et
al
use
articl
qualiti
improv
jama
follow
lead
caus
prevent
hospit
death
fall
result
traumab
central
lineassoci
bloodstream
infectionsc
surgic
errorsd
venou
thromboembolism
medic
error
answer
dthi
accord
us
depart
health
human
servic
healthcar
research
qualitydespit
overal
declin
thrombot
event
due
increas
use
prevent
prophylaxi
pulmonari
embol
result
deep
vein
thrombosi
thromboembol
remain
common
prevent
caus
hospit
deathther
debat
event
defin
prevent
death
suggest
overestim
number
pulmonari
embol
case
classifi
prevent
hospit
death
referencescohen
tapson
vf
bergmann
jf
et
al
venou
thromboembol
risk
prophylaxi
acut
hospit
care
set
endors
studi
multin
crosssect
studi
lancet
harryman
benbow
ew
hay
c
chalmer
n
mortal
pulmonari
embol
decreas
hospit
patient
j
roy
soc
med
pneumocysti
carinii
pcp
pneumonia
like
present
winterb
fallc
summerd
spring
answer
cthere
season
variat
diseas
present
may
due
varieti
environment
factor
increas
level
air
pollut
includ
carbon
monoxid
nitrogen
dioxid
ozon
sulfur
dioxid
particul
matter
wellknown
risk
factor
develop
pneumonia
asthma
copd
pulmonari
diseasesin
studi
patient
hiv
microscop
confirm
pcp
hospit
admiss
significantli
higher
summer
season
increas
temperatur
sulfur
dioxid
level
independ
associ
hospit
admiss
pcp
referencedyaw
k
et
al
environment
risk
factor
pneumocysti
pneumonia
hospit
hiv
patient
clin
infect
di
man
admit
hospit
acut
pancreat
order
determin
sever
diseas
risk
mortal
bedsid
index
sever
acut
pancreat
calcul
follow
variabl
use
calcul
score
except
age
greater
yearsb
bun
greater
impair
mental
statusd
pleural
effusion
white
blood
cell
count
greater
answer
emost
patient
acut
pancreat
recov
without
complic
overal
mortal
rate
ill
sever
tool
develop
predict
outcom
pancreat
bedsid
index
sever
acut
pancreat
bisap
score
may
replac
ranson
criteria
apach
ii
sever
score
modal
assess
sever
pancreat
valid
studi
accur
measur
sever
pancreatitisit
easier
calcul
better
predict
outcom
bedsid
index
sever
acut
pancreat
score
incorpor
five
variabl
determin
sever
bun
greater
mgdl
impair
mental
statu
presenc
sir
age
year
pleural
effus
radiographi
presenc
three
factor
associ
increas
risk
inhospit
mortal
referencepapachrist
gi
muddana
v
yadav
connel
sander
mk
slivka
whitcomb
dc
comparison
bisap
ranson
apach
ii
ctsi
score
predict
organ
failur
complic
mortal
acut
pancreat
j
gastroenterol
minneapoli
heart
institut
studi
outcom
cardiologist
compar
hospitalist
manag
congest
heart
failur
cardiologytr
patient
fewer
readmissionsb
hospitalisttr
patient
fewer
readmissionsc
cost
same
readmiss
rate
answer
acar
must
taken
interpret
studi
look
qualiti
endpoint
among
differ
hospit
servic
studi
often
show
conflict
result
specialti
servic
provid
better
qualiti
costeffici
care
may
depend
resourc
alloc
patient
select
conduct
studyth
research
conduct
minneapoli
heart
institut
track
readmiss
rate
patient
admit
heart
failur
readmiss
rate
cardiologist
vs
patient
discharg
hospitalist
even
though
cardiologist
treat
patient
sever
diseaseresearch
found
cardiologist
better
job
hospitalist
call
patient
discharg
make
sure
patient
outpati
appoint
ensur
followup
nurs
practition
length
stay
similar
specialti
cardiologist
util
resourc
deliv
expens
care
cost
per
case
cardiologist
vs
hospitalist
referenceminneapoli
heart
institut
foundat
heart
failur
patient
treat
cardiologist
rather
hospitalist
fewer
readmiss
american
heart
associ
scientif
session
lo
angel
novemb
follow
shown
effect
improv
sleep
reduc
delirium
patient
icu
back
massagesb
ear
plugsc
eye
shadesd
lorazepam
midazolam
answer
bprevent
delirium
hospit
particular
icu
continu
challeng
simpl
measur
seem
work
best
ear
plug
may
provid
filter
almost
constant
auditori
stimul
occur
hospit
valid
recent
studi
ear
plug
may
facilit
normal
sleep
patternsmedicin
limit
may
contribut
delirium
multipl
studi
shown
associ
sed
drug
delirium
benzodiazepin
strongli
associ
orient
place
time
may
accomplish
promot
visual
clue
import
underestim
disrupt
natur
hospit
environ
effect
cognit
function
frail
patient
referencejon
sf
pisani
icu
delirium
updat
curr
opin
crit
care
male
admit
pyelonephr
urinalys
admiss
perform
show
rbcshpf
wbchpf
nitrit
leukocyt
esteras
posit
urin
cultur
grow
e
coli
patient
treat
antibiot
urinari
tract
infect
readi
dischargewhat
next
step
repeat
urin
cultur
confirm
erad
organismb
renal
ultrasoundc
cystoscopyd
repeat
urinalysi
week
answer
dthe
american
urolog
associ
recommend
urin
test
imag
comput
tomographi
scan
intraven
pyelogram
plu
renal
ultrasound
cystoscopi
patient
age
year
older
red
blood
cell
per
high
power
field
two
three
properli
collect
urinalys
patient
classic
uti
may
account
rbc
seen
would
reason
repeat
urinalysi
weeksh
also
smoker
therefor
risk
uroepitheli
malign
followup
urolog
well
may
appropri
case
referencekhadra
mh
pickard
rs
charlton
powel
ph
neal
de
prospect
analysi
patient
hematuria
evalu
current
diagnost
practic
j
urol
use
diuret
treatment
acut
kidney
injuri
aki
critic
ill
patient
like
result
follow
reduct
mortalityb
improv
renal
recoveryc
shorten
durat
acut
kidney
illnessd
reduct
need
renal
replac
therapy
increas
urin
output
sodium
excret
answer
ealthough
tempt
use
diuret
anur
oliguria
renal
failur
data
support
use
diuret
may
increas
urin
output
sodium
excret
ineffect
even
detriment
prevent
treatment
aki
neither
shorten
durat
aki
reduc
need
renal
replac
therapi
referencedennen
p
dougla
anderson
r
acut
kidney
injuri
intens
care
unit
updat
primer
intensivist
crit
care
med
event
contribut
percentag
death
longterm
followup
patient
communityacquir
pneumonia
cap
b
c
e
less
answer
bcap
increas
risk
cardiovascular
event
day
discharg
plaquerel
plaqueunrel
cardiovascular
event
increas
incid
cardiovascular
event
discharg
communityacquir
pneumonia
patient
myocardi
infarct
congest
heart
failur
arrhythmia
unstabl
angina
stroke
overal
patient
die
long
term
cardiovascular
event
referencesotogomez
n
et
al
pneumonia
arrhythmogen
diseas
j
med
male
admit
diagnosi
urosepsi
admiss
hemoglobin
note
gdl
patient
clinic
improv
third
day
admiss
hemoglobin
note
gdl
hemoccult
studi
neg
fecal
hemoccult
neg
peripher
smear
reveal
schistocyt
blood
smearwhat
like
caus
patient
druginduc
hemolyt
anemia
diha
piperacillintazobactamb
haloperidolc
fentanyld
metformin
answer
aa
varieti
drug
caus
druginduc
hemolysi
drug
list
piperacillintazobactam
highest
risk
follow
metformin
experi
refer
laboratori
cefotetan
ceftriaxon
piperacillin
respons
case
diha
cefotetan
account
major
case
referencesgarratti
g
druginduc
immun
hemolyt
anemia
hematolog
soc
hematol
educ
program
b
salama
piperacillininduc
immun
hemolysi
new
case
concis
review
literatur
transfus
man
admit
medic
intens
care
unit
sepsi
associ
pneumococc
pneumonia
requir
mechan
ventil
well
vasopressor
icuon
third
hospit
day
transfer
servic
urin
output
drop
creatinin
increas
mgdl
acut
tubular
injuri
suspect
next
day
creatinin
continu
rise
slowli
mgdl
stabil
potassium
remain
meql
patient
oligur
urin
output
continu
increas
recov
well
pneumonia
eat
well
particip
physic
therapywhich
follow
would
improv
renal
recoveri
furosemideb
bosentanc
lowdos
dopamin
continu
renal
replac
therapi
crrt
e
hemodialysisf
none
answer
fthere
clear
consensu
often
perform
hemodialysi
set
acut
kidney
injuri
aki
studi
suggest
earli
initi
may
benefici
one
prospect
trial
aggress
dialysi
improv
recoveri
surviv
rate
mani
author
suggest
hemodialysi
may
delay
recoveri
patient
aki
addit
seem
differ
outcom
use
intermitt
hemodialysi
continu
renal
replac
therapi
crrt
sever
aki
hemodialysi
still
consid
standard
therapyonc
dialysi
start
abil
measur
recoveri
limit
patient
urin
output
increas
creatinin
stabil
sepsi
resolv
point
toward
recoveri
renal
functionind
dialysi
aki
includ
hyperkalemia
refractori
medic
therapi
correct
sever
acidbas
disturb
refractori
medic
therapi
sever
azotemia
bun
clinic
studi
fail
establish
benefici
role
lowdos
dopamin
infus
referencesmacedo
e
mehta
rl
renal
replac
therapi
initi
acut
kidney
injuri
semin
dial
pm
zhang
jh
connor
tz
chertow
gm
crowley
st
choudhuri
et
al
intens
renal
support
critic
ill
patient
acut
kidney
injuri
n
engl
j
med
middl
age
younger
adult
elderli
patient
increas
readmiss
rate
follow
condit
heart
failureb
pneumoniac
acut
mid
answer
correct
none
answer
edespit
social
situat
often
differ
young
middleag
adult
readmiss
rate
similar
condit
referencesjenck
sf
william
mv
coleman
ea
rehospit
among
patient
medicar
feeforservic
program
new
eng
j
med
et
al
readmiss
hospit
heart
failur
acut
myocardi
infarct
pneumonia
among
young
middleag
adult
retrospect
observ
cohort
studi
plo
med
man
sever
coronari
arteri
diseas
admit
icu
respiratori
failur
shock
sourc
shock
uncertain
procalcitonin
level
orderedwhich
follow
true
concern
procalcitonin
level
elev
procalcitonin
level
mitig
myocardi
infarctionb
procalcitoninguid
strategi
decreas
patient
mortal
riskc
low
procalcitonin
level
exclud
bacteri
infectiond
high
procalcitonin
level
specif
bacteri
infections
low
procalcitonin
level
make
septic
shock
less
like
answer
ea
low
procalcitonin
level
primarili
predict
decreas
incid
septic
shock
procalcitonin
pct
biomark
exhibit
greater
specif
marker
identifi
patient
sepsi
aid
diagnosi
bacteri
infectionslevel
procalcitonin
increas
sepsi
proport
sever
infect
pct
level
highest
patient
bacteri
infect
level
also
high
patient
viral
fungal
infect
bacteremia
usual
associ
high
procalcitonin
level
low
level
exclud
diagnosi
procalcitonin
level
report
increas
myocardi
infarct
pancreatitisit
exact
clinic
use
yet
determin
use
studi
result
decreas
mortal
yet
procalcitonin
level
predict
declin
success
sourc
control
may
best
use
marker
one
use
may
deescal
antibiot
procalcitonin
prohormon
calcitonin
referencesheyland
procalcitonin
reduc
antibiot
exposur
critic
care
set
crit
care
med
k
meisner
biomark
critic
ill
patient
procalcitonin
crit
care
clin
healthi
hospic
nurs
care
patient
termin
ill
aid
accident
stuck
needl
use
draw
blood
needl
prick
skin
drew
bare
notic
amount
blood
nurs
upset
call
immedi
regard
risk
exposur
hiv
viru
postexposur
treatmentwhat
appropri
action
reassuranceb
treat
test
positivec
start
threedrug
antiretrovir
therapi
continu
daysd
start
antiretrovir
therapi
zidovudin
continu
month
answer
cthi
nurs
immedi
treat
threedrug
antivir
therapi
nurs
risk
infect
base
sourc
type
exposur
hiv
circul
viral
burden
highest
initi
stage
infect
pretermin
advanc
stage
case
herehollow
needl
use
draw
blood
associ
higher
viral
inoculum
solid
needl
expand
regimen
three
drug
day
advoc
center
diseas
control
prevent
hiv
postexposur
prophylaxi
initi
ideal
within
h
injuryhospitalist
nurs
staff
awar
current
protocol
activ
time
manner
referencescardo
dm
culver
kh
ciesielski
c
srivastava
pu
marcu
r
abiteboul
et
al
studi
hiv
seroconvers
healthcar
worker
percutan
exposur
n
engl
j
med
p
deakin
cd
smedley
j
ignor
postexposur
prophylaxi
guidelin
follow
hiv
needlestick
injuri
may
increas
risk
seroconvers
br
j
anaesth
man
etohrel
cirrhosi
admit
hematemesi
take
twice
daili
propranolol
month
esophag
varic
prior
bleed
abstin
alcohol
year
stabil
given
unit
fresh
frozen
plasma
unit
pack
red
blood
cell
inr
admiss
octreotid
infus
start
esophagogastroduodenoscopi
show
three
column
grade
esophag
varic
activ
bleed
sourc
found
hemostasi
achiev
band
ligat
sever
esophag
variceshi
vital
sign
remain
stabl
post
procedur
transfer
back
floorwhich
follow
done
increas
patient
surviv
pack
red
blood
cell
achiev
target
hematocrit
greater
b
continu
octreotid
infus
day
totalc
intraven
ceftriaxon
daili
daysd
fresh
frozen
plasma
correct
coagulopathi
inr
less
intraven
pantoprazol
twice
daili
day
answer
cintraven
antibiot
ceftriaxon
ciprofloxacin
proven
surviv
benefit
patient
cirrhosi
portal
hypertens
bleed
recommend
administ
earli
cours
continu
daysa
target
hematocrit
risk
increas
portal
pressur
excess
fresh
frozen
plasma
administr
increas
portal
pressur
risk
transfusionassoci
lung
injuri
clear
surviv
benefit
intraven
pantoprazol
set
varic
bleed
even
band
ligat
octreotid
infus
lower
portal
pressur
usual
emerg
recommend
h
referencegarciatsao
g
sanyal
aj
grace
nd
carey
w
practic
guidelin
committe
american
associ
studi
liver
diseas
practic
paramet
committe
american
colleg
gastroenterolog
prevent
manag
gastroesophag
varic
varic
hemorrhag
cirrhosi
hepatolog
percentag
c
difficil
infect
commun
acquir
b
c
e
answer
c
difficil
infect
recogn
common
caus
communityacquir
diarrhea
case
thought
occur
within
commun
mani
patient
lack
typic
risk
factor
associ
acquisit
communityacquir
patient
tend
younger
like
femal
hospitalacquir
c
difficileinfect
patient
referencesahil
khanna
mbb
darrel
pardi
md
ms
facg
scott
l
aronson
md
patricia
p
kammer
ccrp
robert
orenstein
jennif
l
st
sauver
phd
w
scott
harmsen
ms
alan
r
zinsmeist
phd
j
gastroenterol
patient
chronic
liver
diseas
hemoglobin
threshold
transfus
red
cell
patient
acut
gastrointestin
bleed
associ
significantli
improv
outcom
gdl
aggress
b
gdl
liber
strategi
c
gdl
restrict
strategi
threshold
answer
cthe
restrict
strategi
gdl
improv
probabl
surviv
decreas
bleed
recent
studi
within
first
day
portalpressur
gradient
increas
significantli
patient
assign
liber
strategi
assign
restrict
strategi
significantli
higher
subgroup
patient
cirrhosi
childpugh
class
b
c
diseas
possibl
due
increas
portal
pressur
seen
groupmort
day
significantli
lower
group
fewer
transfus
addit
patient
lower
transfus
goal
less
like
reble
discharg
hospit
soonerpati
hypovolem
shock
cardiovascular
diseas
might
still
benefit
higher
transfus
threshold
referencevillanueva
c
colomo
et
al
transfus
strategi
acut
upper
gastrointestin
bleed
n
engl
j
med
highrisk
peptic
ulcer
rebleed
success
endoscop
hemostasi
occur
within
mani
day
answer
amost
patient
highrisk
peptic
ulcer
reble
within
first
h
major
clinic
paramet
predict
rebleed
receiv
endoscop
treatment
hemodynam
instabl
admiss
hemoglobin
valu
major
endoscop
predictor
rebleed
activ
bleed
endoscopi
larg
ulcer
size
ulcer
locat
referenceel
ouali
et
al
time
rebleed
highrisk
peptic
ulcer
bleed
success
hemostasi
systemat
review
j
gastroenterol
hepatol
american
heart
associ
guidelin
reduc
heart
failur
readmiss
includ
follow
except
identifi
patient
suitabl
guidelinedirect
medic
therapyb
develop
patient
educ
program
emphas
discharg
carec
develop
home
electron
monitor
systemsd
util
nurs
staff
diseas
management
conduct
patient
followup
day
week
postdischarg
answer
cintervent
rel
inexpens
avail
hospit
chosen
includ
four
simpl
lowtech
intervent
identifi
heart
failur
patient
appropri
goaldirect
therapi
develop
transit
care
discharg
plan
emphas
patient
educ
increas
treatment
complianc
manag
comorbid
condit
effect
tackl
psychosoci
barrier
carereadmiss
continu
signific
reform
topic
seen
maker
overal
system
qualiti
object
measur
referencesdelling
rp
levi
mm
carlet
jm
et
al
surviv
sepsi
campaign
intern
guidelin
manag
sever
sepsi
septic
shock
crit
care
med
vl
lloydjon
emelia
j
et
al
heart
diseas
stroke
updat
report
american
heart
associ
circul
approxim
percentag
patient
treat
deep
vein
thrombosi
dvt
silent
pulmonari
embol
pe
b
c
answer
bsilent
pe
common
patient
dvt
estim
frequenc
silent
pe
high
base
sever
studi
result
though
identif
pe
would
littl
impact
treatmentinvestig
silent
pulmonari
embol
patient
deep
vein
thrombosi
may
benefit
suffer
pulmonari
embol
increas
risk
embol
recurr
especi
first
day
also
concern
pe
found
followup
may
incorrectli
diagnos
new
pe
may
lead
fals
assumpt
anticoagul
fail
patient
despit
factor
guidelin
current
recommend
pe
screen
patient
dvt
referencesmeignan
et
al
systemat
lung
scan
reveal
high
frequenc
silent
pulmonari
embol
patient
proxim
deep
venou
thrombosi
arch
intern
med
et
al
silent
pulmonari
embol
patient
proxim
deep
vein
thrombosi
lower
limb
j
thromb
haemost
male
admit
diagnosi
copd
exacerb
day
ago
develop
acut
respiratori
distress
elev
carbon
dioxid
patient
intub
place
invas
mechan
ventil
improv
treatment
includ
methylprednisolon
albuterol
levofloxacin
toler
wean
trial
well
decis
made
extub
well
remain
hypercapn
transfer
flooron
physic
examin
alert
awak
blood
pressur
mmhg
puls
rate
beat
per
minut
pulmonari
examin
reveal
normal
breath
sound
mild
wheezeswhich
follow
intervent
decreas
patient
risk
reintub
incent
spirometri
everi
hb
noninvas
posit
pressur
ventilationc
nebul
nacetylcystein
inhal
heliumoxygen
mixtur
answer
bnoninvas
posit
pressur
ventil
nppv
h
extub
may
reduc
need
reintub
method
wean
critic
ill
adult
invas
ventil
nppv
significantli
associ
reduc
mortal
ventilatorassoci
pneumonia
mani
circumst
nppv
toleratedth
use
incent
spirometri
reduc
risk
postop
pulmonari
complic
limit
role
routin
manag
nonsurg
patient
follow
extub
nacetylcystein
mucolyt
agent
particular
patient
secret
seem
confound
factor
addit
nacetylcystein
may
trigger
bronchospasm
would
recommend
referenceferr
sellar
j
valencia
et
al
noninvas
ventil
extub
hypercapn
patient
chronic
respiratori
disord
randomis
control
trial
lancet
follow
drug
list
beer
criteria
potenti
inappropri
sue
hydroxyzineb
promethazinec
nitrofurantoind
methyldopa
e
none
answer
emark
h
beer
md
geriatrician
first
creat
beer
criteria
criteria
develop
util
field
expert
statist
model
colleagu
publish
criteria
list
potenti
inappropri
medic
older
patient
updat
criteria
subsequ
publish
regular
basisdrug
list
beer
list
categor
accord
stratifi
risk
tabl
includ
medic
rel
absolut
contraind
list
emphas
stop
medic
unnecessari
high
riskbenefit
ratioth
criteria
use
clinic
care
train
research
healthcar
polici
develop
perform
measur
document
outcom
beer
criteria
appli
peopl
older
age
group
grow
deliveri
safe
effect
health
care
becom
increasingli
import
referencefick
dm
cooper
jw
wade
et
al
updat
beer
criteria
potenti
inappropri
medic
use
older
adult
result
us
consensu
panel
expert
arch
intern
med
man
coronari
arteri
diseas
heart
failur
admit
hospit
worsen
short
breath
outpati
medic
ace
inhibitor
aspirin
betaadrenerg
block
agent
underli
pulmonari
diseaseon
physic
exam
temperatur
puls
rate
beat
per
minut
respiratori
rate
breath
per
minut
blood
pressur
mmhg
arteri
mmhg
mmhg
ph
oxygen
nonbreath
mask
radiograph
chest
reveal
diffus
opac
consist
pulmonari
edema
start
continu
posit
airway
pressur
ventil
cpap
follow
decreas
use
cpap
acut
cardiogen
edema
strokeb
intraaort
balloon
pump
supportc
need
revascular
surgeryd
new
myocardi
infarction
wors
outcom
bipapf
death
answer
frespiratori
compromis
may
develop
patient
cardiogen
pulmonari
edema
patient
may
requir
respiratori
support
continu
posit
airway
pressur
cpap
effect
acut
cardiogen
pulmonari
edema
metaanalysi
demonstr
cpap
reduc
risk
intub
death
protect
new
myocardi
infarct
need
revascular
stroke
use
balloon
pumpposit
airway
pressur
well
use
acut
exacerb
chronic
obstruct
pulmonari
diseas
also
use
effect
cardiogen
edema
wellcurr
data
insuffici
compar
efficaci
safeti
bipap
cpap
referencespet
jv
moran
jl
phillipshugh
j
et
al
effect
noninvas
posit
pressur
ventil
nippv
mortal
patient
acut
cardiogen
pulmonari
edema
metaanalysi
lancet
cl
zhao
yt
liu
qh
et
al
metaanalysi
noninvas
ventil
acut
cardiogen
pulmonari
edema
ann
intern
med
specialti
among
choic
lowest
rate
malpractic
claim
per
practic
physician
neurosurgeryb
hospitalistsc
gastroenterologyd
cardiology
neurolog
answer
bbecaus
hospitalist
field
rel
new
littl
formal
research
malpractic
claim
hospitalist
compar
specialist
internist
liabil
risk
overal
malpractic
claim
hospitalist
appear
low
although
malpractic
claim
hospitalist
low
compar
specialti
area
hospitalist
seen
increas
claim
probabl
occur
hospitalist
continu
expand
scope
practic
particularli
area
comanag
neurosurg
patientsa
studi
close
claim
doctor
compani
found
common
alleg
involv
hospitalist
improp
manag
treatment
cours
delay
treatment
failur
treat
diagnosisrel
error
improp
medic
manag
failur
monitor
physiolog
statu
patient
referencehospit
medicin
societi
hospit
medicin
shm
annual
meet
present
may
common
caus
acut
mesenter
ischemia
superior
mesenter
arteri
embolismb
mesenter
vein
thrombosisc
noninclus
mesenter
vascular
diseas
thrombosi
superior
mesenter
artery
abdomin
aortic
aneurysm
involv
superior
mesenter
arteri
answer
afifti
percent
case
acut
mesenter
ischemia
ami
caus
embol
emboli
usual
origin
left
atrium
ventricl
often
sourc
found
atrial
fibril
recent
myocardi
infarct
emboli
lodg
distal
major
branch
pointabdomin
distent
gastrointestin
bleed
primari
present
symptom
mani
patient
pain
may
abrupt
sever
unrespons
opioid
bowel
becom
gangren
rectal
bleed
sign
sepsi
developif
rapidli
recogn
treat
ami
poor
outcom
consid
patient
abdomin
pain
disproportion
physic
find
presenc
risk
factor
especi
age
older
yearsbecaus
high
mortal
difficulti
diagnosi
mesenter
ischemia
pose
substanti
legal
risk
legal
risk
reduc
earli
surgic
consult
prompt
imag
referencesach
sm
morton
jh
schwartz
si
acut
mesenter
ischemia
surgeri
common
miss
diagnosi
found
autopsi
among
hospit
patient
pulmonari
embolismb
myocardi
infarctionc
aortic
aneurysmd
infection
malign
answer
adu
frequenc
varieti
present
pulmonari
embol
remain
common
miss
diagnosi
found
autopsi
true
past
current
studi
studi
patient
die
unexpectedli
pulmonari
embol
hospit
outsid
reveal
patient
complain
varieti
vagu
symptom
often
week
forti
percent
patient
seen
physician
week
prior
deathin
highrisk
patient
diagnosi
pulmonari
embol
sought
activ
patient
respiratori
symptom
unexplain
altern
diagnosi
referencesaalten
cm
samson
mm
jansen
pa
diagnost
error
need
autopsi
neth
j
med
f
diazgranado
n
messner
h
herridg
ms
relationship
premortem
postmortem
diagnos
critic
ill
bone
marrow
transplant
patient
crit
care
med
wb
de
boer
hhm
kubat
k
qualiti
control
fatal
injur
patient
valu
necropsi
eur
j
surg
male
sever
chronic
obstruct
pulmonari
diseas
admit
icu
develop
acut
delirium
postextub
h
gradual
improv
support
care
transfer
medicin
servic
prepar
discharg
skill
nurs
facil
debilit
cognit
abil
seem
near
baselin
prior
episod
live
famili
concern
cognit
declin
would
impact
abil
live
independentlywhich
follow
statement
correct
patient
admit
diagnosi
develop
delirium
hospit
neurolog
outcom
notb
longterm
cognit
impair
patient
delirium
seen
younger
patientsc
use
antipsychot
hospit
correl
level
cognit
impairmentd
patient
develop
delirium
critic
ill
risk
develop
persist
cognit
impair
year
answer
ddevelop
delirium
predict
cognit
impair
year
critic
ill
case
may
perman
cognit
declin
durat
delirium
independ
predictor
longterm
cognit
impair
note
patient
age
well
develop
delirium
may
predictor
underli
cognit
impair
dementia
referencesbergeron
n
duboi
mj
dumont
et
al
intens
care
delirium
screen
checklist
evalu
new
screen
tool
intens
care
med
jc
gordon
sm
girard
td
et
al
delirium
risk
factor
longterm
cognit
impair
mechan
ventil
icu
survivor
j
respir
crit
care
med
first
day
hospitalist
call
emerg
room
admit
case
abdomin
pain
due
pancreat
ed
physician
start
present
state
patient
alcohol
question
patient
report
histori
alcohol
deni
recent
alcohol
intak
past
sever
year
suspect
still
drink
amylas
lipas
normal
etoh
detect
admit
diagnosi
pancreat
start
iv
fluid
pain
controlsever
day
later
resolut
symptom
gastroenterolog
consult
conclud
pancreat
unlik
undergo
egd
diagnos
sever
gastriti
madewhich
follow
type
medic
error
made
anchoringb
heuristicc
cultur
biasd
frame
answer
aanchor
error
occur
clinician
cling
initi
impress
even
conflict
contradictori
data
accumul
tendenc
frame
clinic
problem
around
first
piec
inform
receiv
often
sens
reward
confid
go
first
instinct
addit
hierarch
natur
medicin
often
place
greater
emphasi
opinion
certain
staffin
case
pancreat
certainli
possibl
data
point
otherwis
tendenc
stick
origin
diagnosi
consid
option
even
face
conflict
evid
referencefurnham
boo
hua
ch
literatur
review
anchor
effect
j
soc
econ
male
hospit
treatment
osteomyel
left
foot
result
chronic
diabet
ulcer
medic
histori
signific
type
diabet
mellitu
hypertens
chronic
kidney
diseas
baselin
serum
creatinin
mgdl
creatinin
chang
admiss
current
follow
renal
servic
patient
initi
broadspectrum
antibiot
subsequ
cultur
grew
klebsiella
discharg
longterm
care
facil
physic
therapi
complet
cours
intraven
antibioticswhich
follow
appropri
rout
access
antibiot
patient
left
subclavian
catheterb
left
intern
jugular
catheterc
peripher
intraven
accessd
right
peripher
insert
central
cathet
answer
ceveri
attempt
made
continu
use
peripher
intraven
access
patient
patient
chronic
kidney
diseas
eventu
requir
hemodialysi
central
cathet
may
interfer
placement
futur
graft
place
discuss
nephrolog
vascular
servic
referencetrainor
borthwick
e
ferguson
periop
manag
hemodialysi
patient
semin
dial
femal
admit
hospit
congest
heart
failur
attend
physician
histori
new
york
heart
associ
class
iii
ischem
cardiomyopathi
past
medic
histori
signific
congest
heart
failur
well
syncop
due
recurr
ventricular
tachycardiaon
third
day
hospit
patient
found
nonrespons
cardiac
arrest
team
call
arriv
time
cardiac
arrest
team
patient
pulseless
chest
compress
begun
famili
room
famili
request
stay
present
resuscit
effortswhich
follow
true
concern
outcom
famili
member
present
cardiac
resuscit
lower
rate
posttraumat
stress
disord
seen
famili
membersb
longer
durat
cardiac
resuscitationc
increas
rate
stress
note
team
membersd
improv
outcomes
wors
outcom
answer
asever
studi
look
presenc
famili
member
cardiac
resuscit
shown
posit
outcom
mani
paramet
offer
elect
remain
present
signific
find
demonstr
lower
risk
posttraumat
stress
disord
famili
member
day
event
clinic
outcom
well
durat
resuscit
found
equal
suggest
durat
code
may
actual
shorter
famili
member
presentsever
current
guidelin
suggest
famili
member
offer
opportun
present
cardiac
resuscit
measur
space
allow
hospit
staff
may
feel
uncomfort
arrang
provid
train
prior
establish
protocol
referencemey
ta
eichhorn
dj
guzzetta
ce
et
al
famili
presenc
invas
procedur
resuscit
experi
famili
member
nurs
physician
j
nur
devic
shown
effect
prevent
decubitu
ulcer
air
mattressb
water
flotat
systemsc
egg
crate
mattressd
foam
mattress
none
effectivef
equal
answer
fclinic
trial
suggest
devic
reduc
pressur
superior
standard
mattress
clear
advantag
one
devic
anoth
goal
maintain
tissu
pressur
less
mmhg
theori
reduct
tissu
pressur
capillari
fill
pressur
allow
adequ
tissu
perfusionani
individu
thought
risk
develop
pressur
ulcer
place
pressurereduc
devicesever
trial
compar
differ
devic
dynam
air
mattress
water
flotat
system
static
support
overlay
term
incid
sever
pressur
ulcer
occur
use
studi
devic
effect
prevent
pressur
ulcer
referencesdaechsel
connin
ta
special
mattress
effect
prevent
decubitu
ulcer
chronic
neurolog
patient
arch
phi
med
rehabil
vilter
rwwhitney
jd
fellow
bj
larson
e
mattress
make
differ
j
gerontol
nur
percent
patient
experienc
refractori
recurr
clostridium
difficil
infect
cdi
cure
via
intestin
microbiota
transplant
imt
b
c
answer
aa
small
studi
patient
sever
refractori
cdi
found
cure
imt
deliv
via
nasogastr
tube
cdi
recurr
imt
groupcurr
sever
random
control
studi
recruit
patient
recurr
cdi
evid
continu
increas
donor
fece
infus
may
superior
antibiot
patient
recurr
cdi
referencevan
nood
e
vriez
nieuwdorp
fuent
zoetend
eg
de
vo
wm
visser
ce
kuijper
ej
bartelsman
jf
tijssen
jg
speelman
p
dijkgraaf
mg
keller
jj
duoden
infus
donor
fece
recurr
clostridium
difficil
n
engl
j
med
femal
present
emerg
room
due
confus
headach
past
h
histori
hypertens
often
uncontrol
treat
hydrochlorothiazid
clonidin
report
famili
blood
pressur
often
systolicon
physic
exam
patient
note
diaphoret
confus
heart
rate
beat
per
minut
blood
pressur
mmhg
tachycard
edema
note
focal
neurolog
deficit
notedlaboratori
studi
signific
creatinin
mgdl
baselin
mgdl
rest
chemistri
within
normal
limitswhich
follow
appropri
blood
pressur
goal
first
hour
treatment
mmhgb
mmhgc
mmhgd
mmhge
mmhg
answer
bthi
patient
hypertens
emerg
hypertens
emerg
formerli
call
malign
hypertens
hypertens
acut
impair
one
organ
system
defin
blood
pressur
greater
progress
target
organ
dysfunct
encephalopathi
intracerebr
hemorrhag
myocardi
infarct
acut
left
ventricular
failur
unstabl
angina
dissect
aortic
aneurysm
eclampsia
hypertens
emerg
differ
hypertens
crisi
former
evid
acut
organ
damageth
goal
therapi
reduc
blood
pressur
within
first
hour
within
next
h
reduct
occur
next
h
except
manag
acut
cerebrovascular
accid
excess
reduct
blood
pressur
precipit
coronari
cerebr
renal
ischemia
possibl
infarctionno
trial
exist
compar
efficaci
variou
agent
treatment
hypertens
emerg
drug
chosen
base
onset
action
eas
use
predict
convent
referencethoma
l
manag
hypertens
emerg
ed
fam
physician
follow
increas
age
plasma
ddimer
concentrationsb
posit
antinuclear
antibodiesc
erythrocyt
sediment
rate
answer
derythrocyt
sediment
rate
plasma
ddimer
concentr
posit
antinuclear
antibodi
increas
elderli
electrolyt
remark
stabl
deviat
valu
young
adult
old
year
result
tradit
threshold
may
result
fals
posit
suggest
ddimer
tradit
cutoff
mcgl
adjust
elderli
popul
mcgl
referencespr
jl
winkler
levi
jh
influenc
variou
patient
characterist
ddimer
concentr
critic
ill
patient
role
prognost
indic
intens
care
unit
set
clin
lab
med
follow
true
concern
signific
lower
gastrointestin
bleed
lgib
diverticulosi
common
etiologyb
colon
angiodysplasia
common
etiologyc
hemorrhoid
common
etiologyd
malign
common
etiology
upper
gastrointestin
tract
respons
case
answer
alow
gastrointestin
bleed
lgib
frequent
caus
hospit
admiss
factor
hospit
morbid
mortal
common
etiolog
lgib
diverticulosi
hemorrhoid
carcinoma
diverticulosi
domin
etiolog
massiv
lgib
public
diverticular
bleed
occur
without
concomit
diverticul
risk
factor
diverticular
bleed
includ
lack
dietari
fiber
constip
advanc
age
use
nonsteroid
antiinflammatori
drug
nsaid
aspirin
patient
present
lgib
sourc
bleed
upper
gastrointestin
gi
tract
referencegay
c
chino
luca
c
tokioka
yamasaki
edelman
da
et
al
acut
lower
gastrointestin
bleed
patient
admit
urban
emerg
medic
center
surgeri
discuss
follow
predictor
cardiac
etiolog
chest
pain
nonrespons
gi
cocktailb
durat
painc
locat
paind
none
answer
aapproxim
million
patient
per
year
present
emerg
depart
chest
pain
adult
common
caus
chest
pain
includ
gastrointestin
coronari
arteri
diseas
musculoskelet
pericard
pulmonari
embol
recent
review
found
patient
chest
pain
suspect
acut
coronari
syndrom
ac
use
gi
cocktail
improv
accuraci
diagnosi
compar
standard
diagnost
protocol
ac
referencechan
mauric
ap
davi
sr
walter
dl
use
gastrointestin
cocktail
differenti
gastrooesophag
reflux
diseas
acut
coronari
syndrom
emerg
set
systemat
review
lung
circ
follow
scenario
appropri
allow
outpati
treatment
communityacquir
pneumonia
cap
male
cap
confusionb
male
cap
respiratori
rate
femal
cap
creatinin
mgdld
femal
cap
low
blood
pressur
confusion
femal
cap
alter
mental
statu
respiratori
rate
blood
pressur
mmhg
answer
bsome
case
cap
safe
treat
outpati
guidelin
develop
assist
appropri
level
care
treat
cap
acronym
stand
c
confus
u
uremia
r
respiratori
rate
greater
b
blood
pressur
low
less
mmhg
systol
less
mmhg
diastol
age
year
greater
categori
assign
point
point
total
mean
patient
treat
outpati
point
total
requir
treatment
medic
ward
point
total
requir
icu
admissionth
male
cap
respiratori
rate
treat
outpati
patient
one
point
age
greater
year
age
curb
score
simpli
serv
guidelin
factor
home
situat
comorbid
access
health
care
must
consid
referencesaujeski
aubl
te
yeali
dm
et
al
prospect
comparison
three
valid
predict
rule
prognosi
communityacquir
pneumonia
j
med
md
donnino
mw
talmor
clardi
p
ngo
l
shapiro
ni
perform
sever
ill
score
system
emerg
depart
patient
infect
acad
emerg
med
femal
present
sepsi
due
pneumonia
admit
intens
care
unit
intub
start
broadspectrum
antibiot
histori
vitamin
defici
prescrib
replac
therapi
note
take
themsh
found
mark
vitamin
deficiencywhich
true
concern
highdos
vitamin
replac
length
stay
improvedb
sixmonth
mortal
improvedc
function
statu
improvedd
above
none
answer
elow
vitamin
statu
link
increas
mortal
morbid
patient
critic
ill
mechan
vitamin
defici
associ
increas
mortal
patient
sepsi
may
relat
immunolog
effectsit
unknown
replac
therapi
improv
outcom
critic
ill
patient
vitamin
defici
benefit
replac
compar
placebo
reduct
length
stay
hospit
mortal
mortal
note
studi
referenceamrein
k
schnedl
c
holl
et
al
effect
highdos
vitamin
hospit
length
stay
critic
ill
patient
vitamin
defici
vitdalicu
random
clinic
trial
jama
femal
admit
uti
accord
previou
cultur
patient
posit
pansensit
escherichia
coli
ciprofloxacin
start
empir
new
cultur
return
decid
dosag
regimen
start
patient
renal
dosag
adjust
equat
util
cockcroftgault
cg
b
modif
diet
renal
diseas
mdrd
c
chronic
kidney
diseas
epidemiolog
collabor
ckdepi
schwartz
answer
ath
cockcroftgault
cg
equat
provid
estim
creatinin
clearanc
equat
commonli
use
determin
drug
dosag
patient
impair
kidney
function
current
mdrd
ckdepi
equat
recommend
drug
dosag
adjust
studi
need
conduct
also
keep
mind
packag
insert
medic
base
recommend
renal
dosag
adjust
cg
equat
fda
label
lastli
schwartz
equat
use
pediatr
popul
referencen
kidney
patient
renal
insuffici
med
assoc
j
foundat
kdoqi
clinic
practic
guidelin
clinic
practic
recommend
chronic
kidney
diseas
j
kidney
di
follow
measur
crohn
diseas
activ
index
number
stoolsb
endoscop
grade
inflammationc
hematocritd
abdomin
pain
take
lomotil
diarrhea
answer
bthe
crohn
diseas
activ
index
cdai
clinic
tool
use
quantifi
symptom
patient
crohn
diseas
major
studi
newer
medic
use
cdai
order
standard
defin
respons
remiss
diseas
cdai
incorpor
subject
assess
qualiti
life
endoscop
factor
system
featureswhil
cdai
consid
standard
assess
diseas
activ
crohn
diseas
valid
index
variedth
inflammatori
bowel
diseas
questionnair
ibdq
develop
incorpor
subject
element
pertain
qualiti
life
well
bowelrel
symptom
activ
index
referencebest
wr
becktel
jm
singleton
jw
kern
f
jr
develop
crohn
diseas
activ
index
nation
cooper
crohn
diseas
studi
gastroenterolog
intern
medicin
resid
sustain
needlestick
injuri
attempt
insert
central
line
patient
servic
resid
contact
sever
emot
distress
due
possibl
hiv
transmissionth
sourc
patient
compet
inform
injuri
refus
provid
consent
human
immunodefici
viru
hiv
test
year
ago
resid
becam
ill
take
postexposur
prophylaxi
pep
similar
exposur
ask
use
blood
complet
blood
count
alreadi
taken
sourc
patient
reason
test
hivwhich
follow
true
statement
hiv
test
sourc
patient
permit
state
without
consentb
hiv
test
sourc
patient
allow
without
consent
statesc
hiv
test
sourc
patient
allow
without
consent
court
orderd
hiv
test
sourc
patient
without
consent
allow
state
answer
dstate
law
regul
hiv
sourc
patient
test
practic
unit
state
controversi
hiv
test
case
occup
exposur
reflect
variat
state
law
polici
state
law
allow
uncons
hiv
test
sourc
patient
case
occup
exposur
state
requir
uncons
hiv
test
variat
exist
numer
procedur
includ
author
uncons
test
test
document
medic
record
inform
test
resultsin
particular
case
prompt
postexposur
treatment
may
need
import
state
polici
understood
allow
rapid
decisionmak
process
occur
referencehenderson
dk
manag
needlestick
injuri
hous
offic
needlestick
jama
follow
symptom
inconsist
diagnosi
syndrom
gb
histori
bilater
weak
abdomin
thigh
painb
bilater
lower
extrem
weak
normal
magnet
reson
imag
head
spinec
patient
bilater
lower
extrem
weak
paresthesia
markedli
decreas
reflex
lower
extremitiesd
patient
present
symmetr
sensori
loss
physic
examin
motor
weakness
facial
droop
dysarthria
answer
present
classic
symptom
often
present
patient
atyp
present
often
delay
diagnosi
often
diagnos
psycholog
reaction
frequent
sent
home
emerg
depart
return
persist
progress
symptom
hour
day
latera
hallmark
ascend
motor
weak
sensori
loss
may
present
motor
weak
predomin
consist
find
univers
flexia
usual
present
syndrom
although
patient
distal
areflexia
painrel
symptom
occur
halfurinari
retent
rare
persist
anal
sphincter
muscl
rare
affect
well
classic
cerebrospin
spinal
find
elev
protein
normal
white
blood
cell
count
present
time
within
first
week
second
week
patient
elev
csf
protein
level
emg
often
show
typic
pattern
present
may
evolv
timecrani
nerv
involv
observ
patient
gb
cranial
nerv
may
affectedth
mean
time
present
clinic
function
nadir
day
patient
reach
nadir
week
progress
symptom
beyond
week
bring
diagnosi
question
recoveri
usual
begin
week
progress
ceas
mean
time
clinic
recoveri
day
referenceshugh
ra
ree
jh
clinic
epidemiolog
featur
syndrom
j
infect
di
suppl
updat
syndrom
j
periph
nerv
syst
attend
hospit
physician
day
shift
check
nighttim
colleagu
notic
slightli
slur
speech
alcohol
breath
otherwis
seem
function
abl
comprehend
patient
present
far
know
troubl
substanc
abus
pastth
appropri
action
notifi
hospit
administrationb
advis
colleagu
seek
care
respect
right
privacyc
inform
colleagu
must
remov
practic
area
immediatelyd
inform
chief
hospit
medicin
answer
cin
circumst
hospit
advoc
respons
manag
situat
hand
appropri
treatment
team
secondarili
respons
colleagu
patient
immedi
definit
action
requiredin
set
suspect
acut
intox
physician
healthcar
provid
provid
patient
care
might
reason
expect
provid
care
near
futur
immedi
remov
practic
set
essenti
case
intervent
may
includ
accompani
suspect
physician
establish
health
care
environ
emerg
depart
secur
need
may
involv
referencebaldisseri
impair
healthcar
profession
crit
care
med
follow
oral
anticoagul
affect
prothrombin
time
partial
thromboplastin
time
thrombin
time
coagul
assay
apixabanb
dabigatranc
rivaroxaband
warfarin
answer
bwarfarin
standard
therapi
oral
anticoagul
decad
side
effect
efficaci
profil
well
known
use
atrial
fibril
venou
thromboembol
vte
prophylaxi
vte
treatment
valvular
heart
diseasenew
agent
develop
effort
improv
upon
warfarin
defici
entir
side
affect
profil
newer
agent
yet
known
drug
list
dabigatran
caus
alter
coagul
assay
referenceeriksson
bi
et
al
compar
pharmacodynam
pharmacokinet
oral
direct
thrombin
factor
xa
inhibitor
develop
clin
pharmacokin
interact
trial
improv
outcom
seen
patient
intracerebr
hemorrhag
whose
blood
pressur
aggress
lower
level
mmhgb
mmhgc
mmhgd
mmhg
answer
arapid
intens
blood
pressur
lower
patient
intracerebr
hemorrhag
ich
appear
relat
less
longterm
disabl
accord
result
interact
intens
blood
pressur
reduct
acut
cerebr
hemorrhag
trial
trial
chines
trial
compar
lower
blood
pressur
target
less
mmhg
systol
within
h
guidelinerecommend
approach
lower
pressur
less
mmhg
drug
commonli
use
urapidil
popular
drug
china
use
extens
unit
statesqualityoflif
assess
suggest
patient
intens
treatment
group
fewer
problem
significantli
better
overal
healthrel
qualiti
life
day
standard
treatment
group
subgroup
underw
brain
imag
small
reduct
hematoma
growth
intens
treatment
group
find
signific
referenceshonn
sk
singh
cheung
pt
alter
hj
dutaret
cg
patel
ak
et
al
emerg
depart
control
blood
pressur
intracerebr
hemorrhag
j
emerg
med
ai
palesch
yy
martin
r
novitzk
j
cruzflor
ehtisham
effect
systol
blood
pressur
reduct
hematoma
expans
perihematom
edema
outcom
among
patient
intracerebr
hemorrhag
result
antihypertens
treatment
acut
cerebr
hemorrhag
studi
arch
neurol
true
concern
cochran
review
found
unit
statesb
offici
partnership
world
health
organizationc
forprofit
organizationd
group
conduct
random
control
trial
answer
bsystemat
review
import
practic
evidencebas
health
care
one
largest
organ
cochran
collabor
cochran
collabor
independ
nonprofit
nongovernment
organ
consist
primarili
volunt
countriesth
group
conduct
systemat
review
random
control
trial
medic
non
medic
intervent
undertak
prospect
trial
cochran
collabor
split
smaller
divis
compos
center
review
group
method
group
fieldson
averag
cochran
systemat
review
take
month
protocol
public
critic
time
frame
although
cochran
review
done
much
dilig
review
come
scrutini
overreach
conclus
referencehil
gb
archi
cochran
legaci
intern
challeng
physician
autonomi
j
clin
epidemiol
often
schedul
result
patient
see
sever
attend
one
hospit
staywhat
report
impact
fragment
hospitalist
care
length
stay
increas
length
stayb
decreas
length
stayc
decreas
patient
satisfactiond
chang
answer
asever
studi
shown
fragment
care
caus
increas
length
stay
lo
one
studi
publish
journal
hospit
medicin
reveal
increas
fragment
associ
increas
day
pneumonia
increas
day
lo
heart
failur
fragment
defin
percentag
patient
seen
physician
physician
provid
major
care
referenceepstein
k
juarez
e
epstein
loya
k
singer
impact
fragment
hospitalist
care
length
stay
j
hosp
med
woman
brought
emerg
depart
progress
cough
fever
confus
past
day
moder
alzheim
diseas
progress
slowli
care
home
daughter
treat
urinari
tract
infect
year
ago
six
month
ago
mammogram
show
suspici
microcalcif
patient
famili
decid
pursu
addit
evaluationth
patient
orient
person
temperatur
puls
rate
beat
per
minut
respiratori
rate
per
minut
blood
pressur
mmhg
oxygen
satur
crackl
heard
lower
lung
fieldswhich
follow
import
piec
inform
obtain
treat
patient
influenza
occurr
local
areab
pneumococc
vaccin
statu
patientc
methicillinresist
staphylococcu
aureu
preval
care
facilityd
prior
urin
cultures
advanc
direct
answer
ea
signific
number
patient
admit
hospit
want
aggress
lifeprolong
care
import
recogn
hospic
palli
care
advanc
direct
offer
individu
famili
face
seriou
lifethreaten
advanc
ill
issuesprotocoldriven
admiss
process
make
easi
overlook
fundament
right
patient
autonomi
goal
care
situat
determin
signific
effort
undertaken
referencecelso
b
meenrajan
triad
matter
palli
medicin
code
statu
health
care
cost
j
hosp
palliat
med
follow
factor
increas
risk
fals
low
btype
natriuret
peptid
level
femal
sexb
kidney
failurec
obesityd
older
age
pulmonari
embol
answer
cobes
increas
risk
fals
low
btype
natriuret
peptid
bnp
level
bnp
especi
help
differenti
dyspnea
result
heart
failur
versu
dyspnea
result
pulmonari
diseas
bnp
good
neg
predict
valu
among
patient
present
emerg
depart
dyspnea
undetermin
caus
bnp
level
less
pgml
accur
exclud
decompens
heart
failur
causeth
clinic
use
ambulatori
set
uncertain
among
ambulatori
patient
establish
heart
failur
normal
rang
bnp
period
clinic
stabil
may
high
pgml
factor
heart
failur
affect
bnp
level
includ
kidney
failur
older
age
femal
sex
increas
bnp
levelth
bnp
level
may
also
elev
mani
caus
ventricular
strain
includ
pulmonari
embol
acut
myocardi
infarct
acut
tachycardia
referencedaniel
lb
clopton
p
bhalla
v
krishnaswami
p
nowak
rm
mccord
j
et
al
obes
affect
cutpoint
btype
natriuret
peptid
diagnosi
acut
heart
failur
result
breath
properli
multin
studi
heart
j
establish
benefit
inferior
vena
cava
ivc
filter
reduct
mortalityb
reduct
recurr
pulmonari
embolismc
reduct
deep
vein
thrombosi
dvt
prevent
need
anticoagul
answer
binferior
vena
cava
filter
wide
use
littl
evid
support
use
inferior
vena
cava
filter
compar
filter
two
studi
studi
show
reduc
recurr
pe
increas
risk
dvt
ivc
filter
associ
reduct
mortal
filter
useivc
filter
commonli
use
prophylaxi
highrisk
patient
includ
trauma
patient
neurosurg
patient
patient
malign
superobes
patient
undergo
surgeri
whether
use
lead
net
benefit
knownwith
ivc
placement
recommend
anticoagul
resum
soon
possibl
filter
insert
filter
alon
effect
treatment
venou
thromboembol
vte
retriev
filter
may
offer
benefit
without
longterm
complic
ivc
filter
referencesghanim
aj
daskalaki
c
eschelman
dj
kraft
wk
fiveyear
retrospect
comparison
review
surviv
neurosurg
patient
diagnos
venou
thromboembol
treat
either
inferior
vena
cava
filter
anticoagul
j
thromb
thrombolysi
hs
young
mj
narayan
ak
hong
k
liddel
rp
streiff
mb
comparison
clinic
outcom
retriev
perman
inferior
vena
cava
filter
j
vasc
interv
radiol
characterist
patient
rate
physician
highest
patient
satisfact
score
lower
mortalityb
decreas
healthcar
expendituresc
decreas
prescript
drug
use
above
none
answer
epati
satisfact
becom
common
metric
hospit
medicin
physician
balanc
provid
qualiti
care
meet
expect
patient
challengingsatisfi
patient
necessarili
healthi
patient
paper
publish
research
univers
california
davi
use
data
nearli
adult
found
satisfi
patient
spent
healthcar
prescript
drug
like
admit
hospit
account
total
healthcar
cost
mortal
also
increasedalthough
studi
prove
causal
effect
question
relationship
patient
satisfact
qualiti
referencefriedberg
mw
gelb
safran
schneider
ec
satisfi
death
spuriou
result
arch
intern
med
man
admit
histori
cough
dyspnea
hemoptysi
also
fever
night
sweat
weight
loss
last
month
signific
medic
histori
smoke
use
alcohol
take
drug
marri
employ
account
take
medicationson
physic
examin
appear
thin
cough
frequent
temperatur
blood
pressur
mmhg
puls
rate
beatsmin
respiratori
rate
pulmonari
examin
show
crackl
right
upper
lung
fieldwhich
follow
appropri
infecti
precaut
order
patient
airborneb
contactc
dropletd
standard
answer
anot
patient
pneumonia
isol
although
patient
appar
risk
factor
mycobacterium
tuberculosi
tb
differenti
patient
cough
greater
week
loss
appetit
unexplain
weight
loss
night
sweat
hoars
fever
fatigu
chest
pain
index
suspicion
substanti
higher
highrisk
group
often
seenairborn
precaut
recommend
patient
infect
microorgan
avian
influenza
varicella
dissemin
zoster
sever
acut
respiratori
syndrom
smallpox
agent
viral
hemorrhag
fever
airborn
precaut
may
depend
local
regul
includ
place
patient
isol
room
higheffici
particul
air
filtrat
neg
pressur
anyon
enter
room
wear
fittest
higher
dispos
respir
patient
also
wear
one
transport
room
goggl
gown
glove
worn
contact
respiratori
secret
anticipatedcontact
precaut
indic
patient
known
suspect
infect
transmit
direct
contact
vancomycinresist
enterococci
methicillinresist
staphylococcu
aureusdroplet
precaut
use
protect
microorgan
transmit
respiratori
droplet
larger
droplet
usual
transmit
distanc
less
ft
exampl
pathogen
diseas
requir
institut
droplet
isol
precaut
includ
neisseria
meningitidi
pneumon
plagu
diphtheria
haemophilu
influenza
type
b
bordetella
pertussi
influenza
mump
rubella
parvoviru
droplet
precaut
includ
place
patient
isol
room
wear
face
surgic
mask
room
wear
goggl
gown
glove
standard
precaut
use
patient
femal
mild
dementia
chronic
kidney
diseas
stage
admit
hospit
pyelonephr
acut
chronic
renal
failur
sinc
admiss
day
ago
improv
clinic
laboratori
paramet
improv
decreas
leukocytosi
repeat
neg
blood
cultur
slight
decreas
serum
creatininedespit
mild
dementia
baselin
patient
recogn
famili
could
express
need
particip
daili
activ
current
medic
ceftriaxon
aspirin
acetaminophenon
hospit
day
develop
mild
delirium
wors
night
last
even
repeatedli
tri
climb
bed
today
pull
intraven
line
even
though
nurs
staff
close
observationon
physic
examin
temperatur
heart
rate
beat
per
minut
blood
pressur
mmhg
patient
appear
restless
orient
person
speech
mildli
distort
repeat
three
numberswhich
follow
recommend
keep
televis
distractionb
initi
bedsid
sitterc
place
bilater
wrist
restraintsd
administr
quetiapin
mg
mgdle
lorazepam
mg
nightli
answer
bcurrent
evid
support
role
sitter
part
manag
patient
delirium
although
use
observ
highrisk
psychiatr
patient
use
sitter
commonli
employ
part
costeffect
manag
deliri
patient
choic
option
proven
benefitsa
limit
factor
util
sitter
obvious
cost
uncertain
circumst
sitter
costeffect
studi
util
sitter
length
stay
durat
delirium
significantli
reduc
howev
fall
help
identif
patient
would
benefit
sitter
use
improv
process
sitter
request
assess
tool
patient
attend
assess
tool
paat
creat
addit
use
train
volunt
suggest
method
increas
sitter
use
man
admit
hemorrhag
stroke
deep
venou
thrombosi
prophylaxi
administ
central
nervou
system
bleed
outpati
medic
includ
aspirin
withheld
wellrecoveri
good
patient
transfer
acut
rehabilit
h
admissionon
physic
examin
patient
rais
affect
arm
leg
bed
sinc
stroke
incap
walk
without
assistancewhat
valu
order
intermitt
pneumat
compress
ipc
devic
patient
reduc
risk
deep
venou
thrombosisb
reduc
mortal
riskc
increas
risk
fallsd
increas
risk
lower
leg
ischemia
amput
answer
aipc
devic
prevent
vte
stroke
thromboembol
common
complic
stroke
lethal
consequ
dvt
prophylaxi
riski
clot
leg
stock
stroke
clot
trial
studi
efficaci
advers
effect
ipc
devic
stroke
popul
day
patient
receiv
ipc
signific
reduct
dvt
compar
none
protect
effect
persist
month
effect
similar
whether
anticoagul
use
also
benefit
ipc
whether
stroke
hemorrhag
fall
may
increas
devic
limit
movement
differ
group
slight
increas
skin
break
ipc
group
compar
ipc
skin
break
ipc
group
higher
incid
ischemia
limb
amput
referencedenni
sandercock
p
reid
j
et
al
effect
intermitt
pneumat
compress
reduct
risk
deep
vein
thrombosi
patient
stroke
clot
multicentr
randomis
control
trial
lancet
woman
admit
pneumonia
readi
discharg
patient
respond
well
therapi
admiss
notic
dishevel
concern
live
arrang
bmi
current
patient
live
alon
report
difficulti
daili
live
daughter
hard
contact
friend
report
patient
home
clutter
dirti
nurs
home
offer
patient
insist
goal
return
home
patient
compet
make
decisionswhich
follow
may
best
assist
improv
safeti
home
ethic
consultationb
perform
home
visitc
insist
higher
standard
safeti
home
avoid
negoti
allow
patient
choos
live
arrangements
avoid
worstcas
scenario
discuss
answer
bselfneglect
common
geriatr
practic
famili
support
increasingli
absent
hospitalist
increas
pressur
reduc
readmiss
selfneglect
associ
readmissionsa
review
articl
smith
et
al
suggest
four
practic
approach
manag
selfneglect
patient
discuss
tactic
gener
work
home
visit
care
provid
team
mean
allow
other
support
patient
home
also
introduc
member
home
care
team
reluct
patient
although
selfneglect
patient
often
lack
resourc
ethic
justif
insist
higher
standard
safeti
ageism
avoid
negoti
gener
use
tri
help
patient
share
goal
uncompromis
approach
avoid
worstcas
scenario
occur
plan
develop
address
situat
referencesmith
ak
lo
b
aronson
l
elder
physician
help
n
engl
j
med
true
concern
use
flumazenil
treat
benzodiazepin
bzd
overdos
use
patient
increas
risk
seizuresb
best
use
may
isol
iatrogen
benzodiazepin
overdosec
use
tricycl
antidepress
overdos
consist
revers
benzodiazepineinduc
respiratori
depress
answer
bflumazenil
competit
bzd
receptor
antagonist
avail
specif
antidot
bzd
benefici
use
acut
bzd
well
establish
flumazenil
consist
revers
central
respiratori
depress
due
bzd
resed
occur
half
patient
follow
closelyin
longterm
bzd
user
flumazenil
may
precipit
withdraw
seizur
flumazenil
use
patient
increas
risk
seizur
head
injuri
coingest
bzd
tricycl
antidepress
agent
may
lower
seizur
threshold
ideal
use
flumazenil
may
isol
iatrogen
bzd
overdos
bzdnaiv
patient
referencemarraffa
jm
cohen
v
howland
antidot
toxicolog
emerg
practic
review
j
health
syst
pharm
male
admit
etoh
withdraw
mild
delirium
develop
patient
becom
agit
comb
transfer
icu
nurs
request
order
physic
restraint
suggest
sitter
none
avail
physic
restraint
appli
patientcompar
nonrestrain
patient
follow
patient
risk
increas
use
sedationb
increas
patient
safetyc
decreas
day
intens
care
decreas
incid
advers
event
answer
ait
import
recogn
potenti
neg
physic
psycholog
consequ
restraint
use
physic
restraint
often
necessari
protect
staff
patient
continu
use
judici
attack
nurs
sudden
seriou
life
threaten
trend
healthcar
literatur
violenc
nurs
appear
grow
problem
globallyphys
restraint
place
shown
requir
higher
dose
benzodiazepin
opioid
antipsychot
medic
patient
prolong
length
stay
intens
care
unit
icu
patient
higher
rate
selfextub
accident
remov
intraven
cathet
urinari
cathet
feed
tube
discharg
elderli
patient
undergon
physic
restraint
higher
level
posttraumat
stress
disord
factor
make
physic
restraint
one
least
prefer
option
referenceschang
ly
wang
kw
chao
ye
influenc
physic
restraint
unplan
extub
adult
intens
care
patient
studi
j
crit
care
mb
kagan
sh
strumpf
ne
et
al
elderli
patient
memori
physic
restraint
use
intens
care
unit
icu
j
crit
care
p
lanka
turner
j
stanaway
se
krishna
percentag
preval
patient
visitor
violenc
staff
highrisk
uk
medic
ward
clin
med
c
colvig
c
chan
sb
restraint
use
elderli
emerg
depart
patient
j
emerg
med
femal
admit
pneumonia
experi
cardiac
arrest
pulseless
electr
activ
first
arriv
peripher
intraven
cathet
becom
dislodg
rapid
review
past
medic
histori
reveal
mark
dehydr
first
moment
code
nurs
report
poor
peripher
vein
difficulti
achiev
venou
access
request
intraoss
io
cannula
place
patient
right
medial
malleoluswhich
follow
addit
inform
true
concern
io
cannula
intraoss
cannul
may
put
patient
greater
risk
cerebr
fat
emboli
bonemarrow
embolib
epinephrin
administr
intraoss
inject
acceptablec
administr
medic
intraoss
rout
dose
infus
rate
achiev
intraoss
cannula
compar
rate
achiev
peripher
intraven
catheter
answer
eio
administr
emerg
medic
proven
effect
patient
need
resuscit
establish
intraven
iv
access
difficultmed
antibiot
epinephrin
blood
product
neuromuscularblock
agent
deliv
intraoss
cannula
requir
dose
adjust
infus
rate
similar
achiev
peripher
intraven
cathet
io
techniqu
fewer
seriou
complic
central
line
may
perform
much
faster
central
peripher
line
vascular
access
difficultpati
righttoleft
shunt
higher
risk
fat
emboli
bonemarrow
compon
migrat
cerebr
circul
intraoss
cannul
avoid
patient
possibl
referencengo
oh
jj
chen
yong
ong
intraoss
vascular
access
adult
use
ezio
emerg
depart
int
j
emerg
med
treatment
hyperkalemia
one
dose
calcium
glucon
provid
cardioprotect
time
period
minb
minc
hd
h
answer
bcalcium
glucon
increas
threshold
potenti
abnorm
elev
hyperkalemia
onset
action
rapid
within
min
durat
action
min
recommend
repeat
dose
ecg
chang
normal
within
mincalcium
agent
firstlin
treatment
sever
hyperkalemia
greater
meql
electrocardiogram
ecg
show
signific
abnormalitiesadministr
calcium
accompani
therapi
help
lower
serum
potassium
level
referencefordjour
kn
walton
doran
jj
manag
hyperkalemia
hospit
patient
j
med
sci
percentag
patient
die
pulmonari
embol
pe
within
first
hour
b
c
answer
patient
die
pulmonari
embolu
within
hour
onset
symptom
fact
demonstr
need
earli
treatment
without
delay
imag
suspect
case
pe
referenceaklog
l
william
cs
byrn
jg
goldhab
sz
acut
pulmonari
embolectomi
contemporari
approach
circul
follow
anticoagul
genotyp
dose
shown
effect
achiev
target
dose
warfarinb
heparinc
lowmolecularweight
heparind
rivaroxaban
answer
aanticoagul
therapi
warfarin
character
wide
variat
among
individu
dose
requir
narrow
therapeut
index
constant
need
monitor
made
use
challengingther
investig
genet
influenc
warfarin
dose
requir
three
singlenucleotid
polymorph
snp
found
play
key
role
determin
effect
warfarin
therapi
coagul
studi
shown
achiev
target
inr
occur
rapidli
patient
undergon
genet
test
whether
clinic
signific
costeffect
uncertain
referencecaraco
blotnick
muszkat
genotypeguid
warfarin
prescrib
enhanc
efficaci
safeti
anticoagul
prospect
random
control
studi
clin
pharmacol
ther
urgent
contact
resid
exposur
blood
hivposit
patient
place
central
line
glove
rip
sutur
needl
remov
glove
notic
blood
hand
small
scratch
mark
sure
scratch
came
fromwhich
follow
best
postexposur
manag
strategi
resid
tenofovir
emtricitabineb
tenofovir
emtricitabin
raltegravirc
tenofovir
emtricitabin
nevirapin
postexposur
prophylaxis
immedi
pregnanc
test
prescript
answer
bthe
us
public
health
servic
recommend
three
drug
use
postexposur
prophylaxi
regimen
regardless
exposur
type
previou
guidelin
offer
two
drug
regimen
exposur
consid
associ
lower
level
transmiss
threedrug
combin
tenofovir
emtricitabin
raltegravir
current
recommend
given
soon
possibl
well
toler
rel
safeti
pregnanc
referencekuhar
dt
henderson
dk
strubl
ka
et
al
updat
us
public
health
servic
guidelin
manag
occup
exposur
human
immunodefici
viru
recommend
postexposur
prophylaxi
infect
control
hosp
epidemiol
impact
advanc
resid
train
cover
patient
icu
follow
day
higher
mortal
differ
interventionsb
differ
mortal
interventionsc
higher
patient
mortal
fewer
interventionsd
lower
patient
mortal
intervent
answer
dtransfer
care
necessarili
increas
complic
interestingli
one
studi
compar
patient
outcom
critic
care
fellow
assign
cover
patient
overnight
icu
mortal
actual
decreas
intervent
increas
effect
could
possibl
explain
impact
new
review
exist
data
increas
dilig
may
occur
deal
new
patient
referenceamar
ackb
barro
bs
barro
ccpp
et
al
nighttim
crosscoverag
associ
decreas
intens
care
unit
mortal
j
respir
crit
care
med
propofol
compar
benzodiazepin
sedat
icu
propofol
benzodiazepin
usag
similar
icu
outcomesb
benzodiazepin
usag
better
outcomesc
propofol
usag
better
outcom
answer
cpropofol
oppos
benzodiazepin
usag
appear
associ
better
outcom
icu
benzodiazepin
shown
induc
delirium
oversed
difficult
titrat
believ
inappropri
dose
benzodiazepin
unavoid
given
unpredict
pharmacokinet
benzodiazepin
may
lead
prolong
icu
stay
increas
mortal
recent
larg
studi
patient
examin
associ
sed
use
icu
outcom
propofol
use
associ
reduct
clinic
import
outcom
includ
icu
mortal
hospit
mortal
icu
length
stay
ventil
remov
sedat
day
propofol
use
expens
without
complic
studi
may
need
establish
reduct
complic
offset
expens
referenceferrel
ba
girard
td
sed
choic
critic
decis
j
respir
crit
care
med
follow
infect
lead
caus
death
among
hivinfect
patient
worldwid
cytomegaloviru
b
escherichia
coli
c
mycobacterium
tuberculosi
pneumocysti
jiroveci
e
staphylococcu
aureu
answer
ctuberculosi
tb
remain
one
import
infecti
complic
hiv
lead
caus
death
among
hivinfect
person
worldwid
develop
countri
malign
cardiovascular
diseas
complic
antivir
agent
emerg
caus
hivrel
mortal
referencenahid
p
menzi
updat
tuberculosi
nontubercul
mycobacteri
diseas
j
respir
crit
care
med
femal
present
acut
ingest
acetaminophen
report
took
approxim
fifteen
mg
tablet
h
ago
famili
member
confirm
amount
time
ingestionwhich
follow
lowest
acut
toxic
ingest
requir
acetylcystein
adult
patient
gb
gc
gd
ge
g
answer
da
singl
dose
g
acetaminophen
enough
warrant
acetylcystein
administr
case
g
ingest
nacetylcystein
therapi
initiatedpati
present
less
h
acetaminophen
overdos
significantli
reduc
risk
hepatotox
acetylcystein
use
although
acetylcystein
effect
given
within
h
ingest
still
benefici
effect
given
late
h
ingest
mortal
rate
acetaminophen
overdos
increas
day
ingest
reach
maximum
day
four
gradual
decreasesacetylcystein
usual
well
toler
consid
total
amount
ingest
uncertain
common
advers
reaction
acetylcystein
treatment
anaphylactoid
reaction
manifest
rash
wheez
mild
hypotens
referenceheard
kj
acetylcystein
acetaminophen
poison
n
engl
j
med
woman
advanc
dementia
hospit
pneumonia
famili
activ
discuss
goal
care
final
decis
made
howev
patient
respiratori
failur
worsen
even
patient
intub
given
ventil
support
famili
decid
comfort
care
howev
request
patient
remain
hospit
best
medic
care
believ
patient
best
care
remain
icuwhich
follow
choic
would
like
promot
wellb
patient
famili
allow
patient
die
ventilatori
support
icu
without
escal
heroic
measuresb
allow
patient
die
ventilatori
support
icuc
extub
allow
patient
die
icud
transfer
patient
icu
answer
dat
point
transfer
icu
appropri
death
icu
may
lead
increas
intervent
increas
suffer
patient
increas
posttraumat
stress
disord
ptsd
among
famili
member
studi
demonstr
stress
famili
member
often
less
floor
less
hectic
quiet
often
conveni
oppos
icu
referencesmularski
ra
hein
ce
osborn
ml
et
al
qualiti
die
icu
rate
famili
member
chest
aa
keat
nl
balboni
ta
et
al
place
death
correl
qualiti
life
patient
cancer
predictor
bereav
caregiv
mental
health
j
clin
oncol
h
lindezwirbl
wt
harrison
da
et
al
use
intens
care
servic
termin
hospit
england
unit
state
j
respir
crit
care
med
black
box
warn
patient
famili
histori
breast
cancerb
famili
histori
thyroid
cancerc
famili
histori
bladder
cancerd
person
histori
colon
cancer
person
histori
rectal
cancer
answer
ath
strongest
warn
us
feder
drug
administr
fda
requir
box
warn
signifi
medic
studi
indic
drug
carri
signific
risk
seriou
even
life
threaten
black
box
warn
signific
effect
drug
usespironolacton
antiandrogen
potassiumspar
diuret
use
women
adult
acn
recalcitr
treatment
although
first
line
help
block
androgen
caus
acn
jawlin
spironolacton
black
box
warn
patient
person
histori
breast
cancer
famili
histori
breast
cancer
referenceshah
nd
montori
vm
krumholz
hm
tu
k
alexand
gc
jackeviciu
ca
geograph
variat
respons
fda
box
warn
rosiglitazon
n
engl
j
med
follow
statement
regard
diagnosi
communityacquir
pneumonia
true
direct
therapi
specif
suspect
caus
organ
effect
empir
therapi
hospit
patientsb
ten
percent
patient
hospit
communityacquir
pneumonia
posit
blood
culturesc
patient
bacteremia
caus
streptococcu
pneumonia
sputum
cultur
posit
casesd
polymeras
chain
reaction
test
wide
avail
util
diagnosi
patient
hospit
communityacquir
pneumonia
case
pneumonia
specif
infecti
agent
identifi
answer
bit
challeng
find
specif
etiolog
communityacquir
pneumonia
overal
caus
found
approxim
case
gener
yield
sputum
cultur
even
case
fulmin
bacterem
pneumococc
pneumonia
yield
sputum
greater
yield
blood
cultur
also
low
empir
broadspectrum
therapi
remain
standard
therapi
expand
polymeras
chain
reaction
assay
show
promis
mean
target
specif
bacteri
etiolog
avail
cost
test
continu
declin
expect
widespread
use
referencehoar
z
lim
ws
pneumonia
updat
diagnosi
manag
pdf
bmj
pmc
pmid
one
follow
factor
suggest
nonpurul
parapneumon
effus
drain
chest
tube
presenc
pneumococc
pneumoniab
pleural
fluid
ph
temperatur
pleural
fluid
nucleat
cell
count
answer
bpleural
effus
common
find
patient
pneumonia
patient
bacteri
pneumonia
develop
parapneumon
effus
sever
studi
document
nonpurul
parapneumon
effus
low
pleural
ph
less
highest
predict
valu
need
pleural
space
drainag
although
organ
caus
pneumonia
associ
pleural
effus
anaerob
organ
streptococcu
pyogen
staphylococcu
aureu
gramneg
bacilli
tend
higher
frequenc
base
number
case
referencesahn
sa
diagnosi
manag
parapneumon
effus
empyema
clin
infect
di
common
caus
nurs
homeacquir
pneumonia
nhap
streptococcu
pneumonia
b
branhamella
catarrhali
c
haemophilu
influenza
legionella
e
staphylococcu
aureu
answer
anhap
close
resembl
communityacquir
pneumonia
cap
nosocomi
pneumonia
usual
pathogen
common
streptococcu
pneumonia
still
common
sever
case
nhap
requir
mechan
ventil
rate
infect
staphylococcu
aureu
enter
gramneg
organ
appear
exceed
pneumonia
referenceselsolh
aa
et
al
etiolog
sever
pneumonia
elderli
j
respir
crit
care
med
pt
k
graham
ac
winslow
bt
springer
kl
treatment
nurs
homeacquir
pneumonia
fam
physician
nurs
pick
urin
sampl
patient
infect
hiv
leav
room
slip
fell
spill
urin
hand
cloth
thorough
wash
hand
soap
water
chang
cloth
ask
advic
understand
time
import
factor
hiv
prophylaxi
exposur
cut
abras
dermat
sourc
patient
hiv
positivewhat
appropri
manag
healthcar
worker
efavirenz
lamivudineb
efavirenz
lamivudin
zidovudinec
kaletra
lamivudin
zidovudin
abacavir
lamivudin
zidovudine
observ
answer
etreat
antiretrovir
therapi
reserv
highrisk
exposur
needlestick
exposur
bloodi
fluid
necessari
case
absenc
blood
saliva
sputum
sweat
tear
fece
nasal
secret
urin
vomitu
carri
low
risk
transmiss
hcv
hiv
referencehenderson
dk
fahey
bj
willi
schmitt
jm
carey
k
koziol
de
risk
occup
transmiss
human
immunodefici
viru
type
associ
clinic
exposur
prospect
evalu
ann
intern
med
man
admit
dysarthria
right
lower
extrem
weak
min
durat
histori
diabet
hypercholesterolemia
hypertens
take
aspirin
hydrochlorothiazid
metformin
simvastatin
daili
ct
head
without
contrast
show
acut
abnorm
tpa
administ
radiolog
intervent
lab
subsequ
ct
scan
day
later
head
demonstr
ischem
stroke
involv
right
pariet
area
echocardiographi
heart
normalwhat
intervent
done
reduc
recurr
stroke
add
clopidogrel
dischargeb
aspirin
warfarin
dischargec
discontinu
aspirin
start
warfarind
add
dipyridamol
discharge
noth
els
optim
treatment
answer
dstart
clopidogrel
alon
ad
dipyridamol
aspirin
reason
option
guidelin
seventh
american
colleg
chest
physician
accp
confer
antithrombot
thrombolyt
therapi
suggest
combin
extendedreleas
dipyridamol
aspirin
efficaci
clopidogrelth
patient
alreadi
aspirin
addit
dipyridamol
shown
reduc
risk
stroke
recurr
esprit
profess
trial
addit
clopidogrel
aspirin
increas
risk
cerebr
gi
bleed
substanti
increas
benefit
anticoagul
use
reduc
stroke
recurr
referencesalb
gw
amarenco
p
easton
jd
sacco
rl
teal
p
antithrombot
thrombolyt
therapi
ischem
stroke
seventh
accp
confer
antithrombot
thrombolyt
therapi
chest
suppl
jf
bushnel
c
bodenalbala
b
braun
lt
bravata
dm
chaturvedi
et
al
guidelin
primari
prevent
stroke
statement
healthcar
profession
american
heart
associationamerican
stroke
associ
stroke
woman
insulindepend
diabet
admit
epigastr
pain
esophagogastroduodenoscopi
egd
perform
reveal
mild
gastric
mucos
erythema
addit
abnorm
start
metoclopramid
presum
diabet
gastroparesiswhich
follow
true
regard
metoclopramid
risk
tardiv
dyskinesiab
longterm
efficaci
provenc
improv
symptom
tachygastria
bradygastriad
improv
surviv
gastoparetics
patient
shortest
cours
minim
dose
requir
everi
effort
made
avoid
chronic
use
metoclopramid
answer
emetoclopramid
approv
shortterm
use
diabet
gastroparesi
one
option
avail
five
control
trial
evalu
efficaci
metoclopramid
treatment
diabet
gastroparesi
benefit
limit
metoclopramid
demonstr
effect
shortterm
treatment
gastroparesi
sever
week
longterm
efficaci
proven
one
studi
consist
benefit
observ
use
metoclopramid
month
surviv
diabet
gastroparesi
impact
metoclopramid
use
symptom
bradygastria
improv
diabet
may
also
tachygastr
symptom
would
worsen
improv
metoclopramiden
guidelin
estim
risk
develop
tardiv
dyskinesia
td
metoclopramid
chronic
use
metoclopramid
appear
increas
risk
develop
td
prior
initi
treatment
metoclopramid
may
reason
obtain
inform
consent
physician
patient
famili
member
also
document
medic
chart
medicoleg
reason
referenceshasl
wl
gastroparesi
symptom
evalu
treatment
gastroenterol
clin
north
butterfield
pamer
c
mackey
ac
tardiv
dyskinesia
risk
metoclopramid
use
us
market
withdraw
cisaprid
j
pharm
assoc
white
femal
present
nurs
home
wateri
diarrhea
day
found
posit
clostridium
difficil
first
occurr
start
metronidazol
mg
po
tidwhich
follow
medic
inpati
profil
polyethylen
glycolb
loperamidec
bd
cholestyramin
answer
cpolyethylen
glycol
osmot
agent
would
increas
bowel
movement
loperamid
act
opioid
intestin
muscl
receptor
inhibit
peristalsi
prolong
transit
time
gi
tract
neither
would
appropri
acut
clostridium
difficil
infect
loperamid
would
potenti
inhibit
excret
toxin
lead
toxic
megacolon
hand
polyethylen
glycol
would
caus
cramp
discomfort
patient
alreadi
experienc
frequenc
bowel
movementscholestyramin
shown
modest
activ
reduc
stool
frequenc
recommend
use
patient
sever
case
c
difficil
coliti
cholestyramin
bind
vancomycin
must
dose
separ
use
combin
antibiot
referencecohen
sh
et
al
clinic
practic
guidelin
clostridium
difficil
infect
adult
updat
societi
healthcar
epidemiolog
america
shea
idsa
infect
cont
hosp
epidemiol
percent
empir
antimicrobi
regimen
remain
unchang
day
hospit
b
c
e
answer
cbroadspectrum
empir
therapi
common
mani
case
protocol
driven
benefici
mani
instanc
certainli
mani
antibiot
guidelin
improv
mortal
howev
often
reluct
deescal
regimen
work
even
clinic
sign
infect
longer
presentdeescal
antibiot
indic
associ
lower
mortal
h
suggest
review
microbiolog
data
patient
improv
deescal
broadspectrum
antibiot
narrow
spectrum
procalcitonin
level
also
util
guid
therapi
mani
healthcar
system
develop
antibiot
stewardship
program
address
issu
referencesdellit
th
et
al
infecti
diseas
societi
america
societi
healthcar
epidemiolog
america
guidelin
develop
institut
program
enhanc
antimicrobi
stewardship
clin
infect
di
j
gutierrezpizarraya
escorescaortega
et
al
deescal
empir
therapi
associ
lower
mortal
patient
sever
sepsi
septic
shock
intens
care
med
follow
acut
exacerb
copd
predict
score
inhospit
mortalityb
risk
mechan
ventilationc
length
stayd
longterm
mortality
none
answer
dthe
system
repres
simpl
tool
categor
patient
acut
exacerb
copd
calcul
measur
b
blood
urea
nitrogen
alter
mental
statu
p
puls
age
patient
year
age
class
patient
older
year
age
score
stratifi
base
upon
number
risk
factor
class
one
risk
factor
class
two
risk
factor
class
three
risk
primarili
use
predict
inhospit
sever
possibl
need
intub
predict
outofhospit
mortalityth
bode
index
util
predict
longterm
outcom
patient
copd
compos
bodymass
index
airflow
obstruct
dyspnea
exercis
referencescelli
br
cote
cg
marin
jm
et
al
bodymass
index
airflow
obstruct
dyspnea
exercis
capac
index
chronic
obstruct
pulmonari
diseas
n
engl
j
med
af
sun
x
johann
rs
yaitan
tabak
yp
valid
novel
risk
score
sever
ill
acut
exacerb
copd
chest
alcohol
withdraw
seizur
usual
occur
h
cessat
drinkingb
h
cessat
drinkingc
h
cessat
drinkingd
h
cessat
drinking
week
cessat
drink
answer
cwithdraw
seizur
occur
within
h
alcohol
cessat
alcohol
withdraw
may
present
seizur
first
sign
symptom
withdraw
may
occur
seizur
abat
patient
alcohol
withdraw
seizur
progress
delirium
tremen
alcohol
withdraw
seizur
usual
occur
recur
twice
gener
resolv
spontan
withdraw
gener
occur
h
last
drink
referenceey
f
schuster
felgenhau
n
pfab
r
strubel
saugel
b
risk
assess
moder
sever
alcohol
withdraw
predictor
seizur
delirium
tremen
cours
withdraw
alcohol
alcohol
academ
versu
nonacadem
hospitalist
servic
compar
follow
paramet
increas
length
stay
lo
b
increas
allcaus
inhospit
mortalityc
decreas
allcaus
mortalityd
chang
observ
answer
studi
compar
teach
hospitalist
servic
staffonli
hospitalist
servic
lo
significantli
shorter
staffonli
hospitalist
group
factor
remain
referenceeverett
gd
anton
mp
jackson
bk
swigert
c
uddin
n
comparison
hospit
cost
length
stay
associ
gener
internist
hospitalist
physician
commun
hospit
j
manag
care
follow
situat
patient
warrant
stress
ulcer
prophylaxi
platelet
count
inr
patient
icu
ventil
h
c
highdos
corticosteroid
use
answer
dstress
ulcer
prophylaxi
recommend
follow
major
risk
factor
respiratori
failur
requir
mechan
ventil
like
greater
h
coagulopathi
defin
platelet
count
inr
ptt
control
prophylact
treatment
dose
anticoagul
constitut
coagulopathi
addit
risk
factor
warrant
stress
ulcer
prophylaxi
follow
head
spinal
cord
injuri
sever
burn
bsa
hypoperfus
acut
organ
dysfunct
histori
gi
ulcerbleed
within
year
high
dose
corticosteroid
liver
failur
associ
coagulopathi
postop
transplant
acut
kidney
injuri
major
surgeri
multipl
trauma
referencesashp
commiss
therapeut
ashp
therapeut
guidelin
stress
ulcer
prophylaxi
j
health
syst
pharm
jm
stressrel
mucos
diseas
intens
care
unit
updat
prophylaxi
aacn
adv
crit
care
